[go: up one dir, main page]

WO2017045955A1 - Composés hétérobicycliques - Google Patents

Composés hétérobicycliques Download PDF

Info

Publication number
WO2017045955A1
WO2017045955A1 PCT/EP2016/070847 EP2016070847W WO2017045955A1 WO 2017045955 A1 WO2017045955 A1 WO 2017045955A1 EP 2016070847 W EP2016070847 W EP 2016070847W WO 2017045955 A1 WO2017045955 A1 WO 2017045955A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
spp
compounds
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2016/070847
Other languages
English (en)
Inventor
Devendra VYAS
Ramakrishnan VALLINAYAGAM
Harish SHINDE
Sunderraman SAMBASIVAN
Ashokkumar Adisechan
Jean-Yves WACH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of WO2017045955A1 publication Critical patent/WO2017045955A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Definitions

  • Heterobicyclic compounds Description The present invention relates to substituted heterobicyclic compounds of formula I as agrochemical pesticides. Furthermore, the present invention relates to processes and intermediates for preparing compounds of formula I and to active compound combinations comprising them. Moreover, the present invention relates to agricultural or veterinary
  • compositions comprising the compounds of formula I, and to the use of the compounds of formula I or compositions comprising them for combating or controlling invertebrate pests and/or for protecting crops, plants, plant propagation material and/or growing plants from attack and/or infestation by invertebrate pests.
  • the present invention also relates to methods of applying the compounds of formula I.
  • the present invention relates to seed comprising compounds according to the invention.
  • Invertebrate pests and in particular insects, arachnids and nematodes destroy growing and harvested crops and attack wooden dwelling and commercial structures, thereby causing large economic loss to the food supply and to property. Accordingly, there is an ongoing need for new agents for combating invertebrate pests.
  • 3-pyridy,l 5-6 fused heterocycle are known for pesticidal use in a patent publication WO 2015038503. Further, 5-membered 3-pyridyl heterocycles represent an important class of insecticides. 3-pyridyl thiazoles and in particular tri- and tetra-aryl 3-pyridyl thiazoles have been found to be pesticidally active. In this regard, reference is, made to publications
  • substituted heterobicyclic compounds of formula I as depicted and defined below, including their stereoisomers, their salts, in particular their agriculturally or veterinarily acceptable salts, their tautomers and their N-oxides.
  • a and B are selected from N and CR 1 ;
  • R 1 is independently selected from H, halogen, CN, NO2, C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio and C1-C4 haloalkylthio;
  • Q is a moiety selected from the group Q1 and Q2;
  • X is N, N-oxide or CR ⁇
  • R A is H, halogen, C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 haloalkylthio, S(0)-Ci-C 4 alkyl, S(0) 2 -Ci-C 4 alkyl, C(0)NHR B ;
  • R B is C1-C4 alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4
  • phenyl or a 5-, 6-, 7-, 8- or 9-membered saturated, partially or fully unsaturated heterocycle comprising 1 , 2 or 3 heteroatoms O, N or S, which rings are unsubstituted or substituted by halogen, NO2, CN, OH, SH, C1-C4 alkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 4 -alkylthio, Ci-C 4 -alkylsulfinyl, Ci-C 4 -alkylsulfonyl, Ci-C 6 -haloalkylthio or Si(R xx ) 3 ;
  • R xx are selected from H, C1-C6 alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C4-alkoxy-Ci-C4-alkyl,
  • Y 1 , Y 2 and Y 3 are each independently C, N or NR ⁇ ; and together forms annulated saturated, partially or fully unsaturated ring;
  • n 0, 1 or 2;
  • R 2 is a substitution on Y 1 , Y 2 and Y 3 being a carbon atom, and R 2 is independently selected from
  • halogen CN, NO2, Ci-Cio-alkyl, C1-C4 haloalkyi, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio or C1-C4 haloalkylthio, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, Cs-Cs-cycloalkenyl,
  • ⁇ denotes the bond to the atom on which R 2 is present
  • X is NR 3 , O, or S
  • R 3 is H, CN, NO2, Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, which each independently are unsubstituted or substituted by identical or different R 11 ,
  • heterocyclic ring comprises 1 , 2 or 3 heteroatoms independently selected from the group consisting of O, N, and S, and is unsubstituted or substituted by
  • substituents R 14 said substituents R 14 being identical or different from one another if more than one substituent R 14 is present, and wherein said N and/or S atoms, independently from one another are un-oxidized or oxidized;
  • substituents R 14 are selected independently from one another if more than one substituent R 14 is present,
  • R 5 , R 6 , R 7 are selected independently from one another from the group consisting of H, halogen, CN, N 3 , N0 2 , -SCN, d-Ce-alkyl, Ci-C 6 -haloalkyl, Ci-C 6 -alkoxy, Ci-C 6 -haloalkoxy, Ci-C 6 - alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylthio, Cs-Cs-cycloalkyl, C3- Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, Si(R xx ) 3 , OR 12 , OSO2R 12 , S(0) n R 12 , S(0) n NR 3a R
  • R 5 and R 6 together forms a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially or fully
  • R 7 unsaturated heterocycle together with the C atom to which they are bonded to and R 7 is selected from the group above;
  • R 8 , R 9 are selected independently from one another from the group consisting of H, CN, C1-C10- alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the aforementioned aliphatic and cycloaliphatic radicals are unsubstituted or substituted by substituents; or R 8 and R 9 together are part of a C2-C7-alkylene, C2-C7-alkenylene or C2-C7-alkynylene chain and form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially or fully unsaturated heterocycle together with the N atom they are bonded to, wherein 1 to 4 of any of the Chb groups in the C2-C7-alkylene chain or 1 to 4 of any of the CH2 or CH groups in the C2-C7-alkenylene chain or 1 to 4 of any of the CH2, CH or C groups in the C2-C7
  • a 3-, 4-, 5-, 6- or 7-membered saturated, partially or fully unsaturated heterocycle comprising 1 , 2 or 3 heteroatoms selected from O, N and S, is unsubstituted or substituted by substituents R 14 , selected independently from one another, and wherein the N and S atoms of the heterocycle independently from one another are un-oxidized or oxidized; and wherein
  • R 11 is H, halogen, CN, N 3 , N0 2 , SCN, Ci-C 6 -alkyl, Ci-C 6 -haloalkyl, Ci-C 6 -alkoxy, Ci-C 6 - haloalkoxy, Ci-C6-alkylthio, Ci-C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylthio, Cs-
  • R 12 is H, CN, d-d-alkyl, Ci-C 6 -haloalkyl, Ci-C 6 -alkoxy, Ci-C 6 -haloalkoxy, Ci-C 6 -alkylthio, d- C6-alkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylthio, d-d-cycloalkyl, d-d-cycloalkyl-
  • R 13a , R 13b are each independently from one another selected from the group consisting of H, d- Ce-alkyl, d-d-haloalkyl, d-d-alkoxy, d-d-haloalkoxy, d-d-alkylthio, d-d- haloalkylthio, d-d-cycloalkyl, d-d-halocycloalkyl, d-d-alkenyl, d-d-haloalkenyl, d- d-alkynyl, C 2 -C 6 -haloalky
  • R 13a and R 13b are together a d- alkylene or d-d alkenylene chain and form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially or fully unsaturated heterocycle together with the N atom they are bonded to, wherein the alkylene chain or alkenylene chain may contain one or two heteroatoms selected from O, S and N, and is unsubstituted or substituted by halogen, d-d-alkyl, d-d-haloalkyl, d-d-alkoxy, d-d-haloalkoxy, d-d-alkylthio, d- d-haloalkylthio, d-d-cycloalkyl, d-d-halocycloalkyl, d-d-alkenyl, d-d-haloalkenyl, d-d-alkynyl, d-d haloalkynyl,
  • phenyl unsubstituted or substituted by halogen, CN, NO2, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci- C6-alkoxy or Ci-C6-haloalkoxy,
  • R 17 , R 18 are each independently from one another selected from the group consisting of H, Ci-
  • R 19 is H, halogen, CN, N0 2 , OH, SH, SCN, SF 5 , Ci-Ce-alkoxy, Ci-Ce-haloalkoxy, Ci-C 6 - alkylthio, Ci-C 6 -alkylsulfinyl, Ci-C 6 -alkylsulfonyl, Ci-C 6 -haloalkylthio, Si(R xx ) 3 ,
  • Ci-C6-alkyl C2-C6-alkenyl, C2-C6-alkynyl, C 3 -C8-cycloalkyl, which is unsubstituted or substituted by substituents selected from halogen and C1-C4 alkoxy;
  • phenyl benzyl, pyridyl, or phenoxy, wherein the radicals are unsubstituted or substituted by substituents selected from halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, C1-C6 haloalkoxy or (Ci-C6-alkoxy)carbonyl;
  • radicals may be unsubstituted or substituted by substituents selected from halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C1-C6- alkoxy, C1-C6 haloalkoxy and (Ci-C6-alkoxy)carbonyl; or,
  • R 21a and R 21b together are a C2-C6 alkylene chain forming a 3- to 7-membered saturated
  • alkylene chain may contain 1 or 2 heteroatoms selected from O, S, and N, and is unsubstituted or substituted by halogen, Ci-C4-haloalkyl, Ci-C4-alkoxy or C1-C4- haloalkoxy, and wherein the heteroatoms N and S independently from one another are un-oxidized or oxidized;
  • R 22 is H, halogen, N0 2 , CN, OH, SH, Ci-C 6 -alkoxy, d-C 6 -haloalkoxy, Ci-C 6 -alkylthio, Ci-C 6 - alkylsulfinyl, Ci-C 6 -alkylsulfonyl, Ci-C 6 -haloalkylthio, Si(R xx ) 3 , Ci-C 6 -alkyl, C 2 -C 6 -alkenyl, C2-C6-alkynyl, Cs-Cs-cycloalkyl, which is unsubstituted or substituted by substituents selected from the radicals halogen, Ci-C4-alkoxy, phenyl, benzyl, pyridyl, or phenoxy, wherein the radicals are unsubstituted or substituted by halogen, Ci-C6-alkyl, C1-C6- haloalky
  • R 22 on two adjacent C atoms together are a C2-C6 alkylene chain or C2-C6-alkenylene chain, which form together with the C atom they are bonded to a 3-, 4-, 5-, 6- or 7-membered saturated, partially or fully unsaturated heterocycle comprising 1 or 2 heteroatoms selected from O, S, and N, and which is unsubstituted or substituted by substituents selected from the radicals halogen, Ci-C4-haloalkyl, Ci-C4-alkoxy or Ci-C4-haloalkoxy, and wherein the heteroatoms N and S of the heterocyclic ring independently are un-oxidized or oxidized;
  • R 2A is in each case independently selected from H or the substituents as defined for R 2 ;
  • the compounds of formula I can principally be prepared by procedures as given in below schemes.
  • Catalysts can be generated from transition metals such as Pd catalyst, for example palladium (II) acetate (“Pd(0Ac)2”) or Tris(dibenzylideneacetone)dipalladium(0) (“Pd2(dba)3").
  • Pd catalyst for example palladium (II) acetate (“Pd(0Ac)2") or Tris(dibenzylideneacetone)dipalladium(0) (“Pd2(dba)3").
  • Suitable ligands include mono- or bi- dentate ligands such as triphenylphosphine ("PPh3"), tricyclohexyl phosphine (“PCV3”), tri- tertiary butyl phosphine P(t-Bu)3, 2-Dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl ("x- phos”), 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene (“xantphos”), 2- Dicyclohexylphosphino-2',6'-dimethoxybiphenyl (“s-phos”), and 1 ,1 '-Ferrocenediyl- bis(diphenylphosphine) (“dppf”).
  • Suitable bases include carbonates such as sodium carbonate or cesium carbonate, phosphates such as potassium triphosphate, amines such as
  • Typical solvents include ethers such as tetrahydrofuran, dioxane, aromatic hydrocarbons such as toluene, alcohols such as ethanol, formamides such as dimethyl formamide, water or mixtures thereof.
  • Typical reaction temperatures range from ambient temperature to the boiling point of the solvent.
  • Compounds of formula 1 wherein LG is halogen can be prepared from the corresponding amines by treatment with a source of ON + such as isoamyl nitrite or t-butyl nitrite or nitrous acid in the presence of a halogen source such as CuBr2 or benzy triethylammonium bromide (BnNEt.3 + Br).
  • a source of ON + such as isoamyl nitrite or t-butyl nitrite or nitrous acid
  • a halogen source such as CuBr2 or benzy triethylammonium bromide (BnNEt.3 + Br).
  • Preferred reaction conditions include aqueous or organic solvents such as tetrahydrofuran or acetonitrile, and reaction temperatures ranging from 0 °C to the boiling point of the solvent.
  • Compounds of Formula 1 wherein LG is CI or Br can also be prepared from the corresponding hydroxy compounds by treatment with a halogenating agent such as POCI3, PCI5, PBr3 or SOC .
  • Compounds of formula 1 wherein LG is OMs or OTf can also be prepared from the corresponding hydroxy compounds by treatment with MsCI or Tf20.
  • Scheme-2 Compound of formula I can alternatively be prepared from compounds of formula 3 and compounds of formula 4, by using below procedure.
  • Compounds of Formula I (wherein Q is Q1 or Q2) can also be prepared coupling of a compound of formula 3 with a compound of formula 4 (wherein LG is a suitable leaving group such as CI, Br, I, Tf or Nf) in the presence of a base, catalyst and an appropriate ligand.
  • a variety of catalysts can be used in the method of Scheme 2, and these can be generated from a transition metal species such as copper or Pd (for example complexes such as Pd(OAc)2 or Pd2(dba)3) and a ligand.
  • Typical ligands may be mono- or bi-dentate, and include PP i3, PCV3, Pt-Bu3, x-phos, xantphos, s-phos, and dppf.
  • Suitable bases include carbonates such as sodium carbonate or cesium carbonate, phosphates such as potassium triphosphate, amines such as ethyldiisopropylamine or alkoxides such as sodium tert-butoxide.
  • Additives such as molecular sieves, Bu 4 NBr or copper or silver salts (e.g. AgOAc) can be beneficial.
  • Typical reaction solvents include tetrahydrofuran, dioxane, toluene, ethanol, dimethyl formamide, water, or mixtures thereof.
  • Typical reaction temperatures range from ambient temperature to the boiling point of the solvent. For examples, see Chemical Communications 201 1 , 47, 5043; Journal of the American Chemical Society 2010, 132, 3674; Heterocycles 201 1 , 83, 1371 ; US
  • Compounds of formula 3 can be prepared from the corresponding amine compounds by treatment with a source of ON + such as isoamyl nitrite or t-butyl nitrite.
  • a source of ON + such as isoamyl nitrite or t-butyl nitrite.
  • Preferred reaction conditions include ethereal solvents such as tetrahydrofuran at temperatures ranging from ambient temperature to the boiling point of the solvent.
  • halogenating agent such as N- bromosuccinimide, N-Chlorosuccinamide, Br2 or thionyl chloride in a suitable solvent such as dichloromethane, chloroform, dimethyl formamide (“DMF”), N-methyl-2-pyrrolidone (“NMP”) or acetic acid at temperatures ranging from ambient temperature up to the boiling point of the solvent the resultant region-isomeric products can be separated by silica gel column
  • Scheme-4 compounds of formula I-Q1 -G to I-Q1 -L (as defined hereinafter) can be prepared from compounds of formula 6 by using below procedure.
  • alcoholic organic solvent such as methanol, ethanol, n-propanol, isopropanol, n-butanol, and tert.-butanol
  • a catalytic amount of acid such as HCI, sulphuric acid or acetic acid
  • base for example tertiary amines, such as trimethylamine, triethylamine, triisopropylethylamine and N-methylpiperidine, pyridine, substituted pyridines, such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines.
  • tertiary amines such as trimethylamine, triethylamine, triisopropylethylamine and N-methylpiperidine
  • pyridine substituted pyridines, such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines.
  • halogenating agent such as N- bromosuccinimide, N-Chlorosuccinamide, Br2 or thionyl chloride in a suitable solvent such as dichloromethane, chloroform, dimethyl formamide, NMP or acetic acid at temperatures ranging from ambient temperature up to the boiling point of the solvent the resultant region-isomeric products can be separated by silica gel column chromatography.
  • Scheme-6 compounds of formula I-Q2-D to I-Q2-F (as defined hereinafter) can be prepared from compounds of formula 8 by using below procedure.
  • alcoholic organic solvent such as methanol, ethanol, n-propanol, isopropanol, n-butanol, and tert.-butanol
  • a catalytic amount of acid such as HCI, sulphuric acid or acetic acid
  • base for example tertiary amines, such as trimethylamine, triethylamine, triisopropylethylamine and N-methylpiperidine, pyridine, substituted pyridines, such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines.
  • Scheme-7 compounds of formula I-Q1 -A to I-Q1 -F (as defined hereinafter) can be prepared from compounds of formula 9 and compounds of formula 10 by using below procedure.
  • B(-OC(CH3) 2 C(CH3) 2 0-) or BF3K) can be reacted with the compounds of formula 10 under Suzuki cross-coupling conditions as mentioned in scheme 7 above, to obtain compounds of formula I-Q1 -A to I-Q1 -F.
  • Such transformation is usually carried out in the presence of Pd catalyst (for example complexes such as Pd(OAc) 2 or Pd 2 (dba)3), base and a ligand.
  • Pd catalyst for example complexes such as Pd(OAc) 2 or Pd 2 (dba)3
  • Typical ligands may be mono- or bi-dentate, and include PP i3, PCV3, Pt-Bu3, x-phos, xantphos, s-phos, and dppf.
  • Suitable bases include carbonates such as sodium carbonate or cesium carbonate, phosphates such as potassium triphosphate, amines such as ethyldiisopropylamine or alkoxides such as sodium tert-butoxide.
  • Typical solvents include tetrahydrofuran, dioxane, toluene, ethanol, dimethyl formamide, water or mixtures thereof. Typical reaction temperatures range from ambient temperature to the boiling point of the solvent.
  • the Suzuki reaction is known from the literature, for example J. P. Wolfe, J. S. Nakhla, the Suzuki Reaction in Name Reactions for homologations, John Wiley & Sons, Inc., Hoboken, N. J, 2009, Pt. 1 , 163.
  • Scheme-8 compounds of formula I-Q2-A to I-Q1 -C (as defined hereinafter) can be prepared from compounds of formula 9 and compounds of formula 1 1 by using below procedure.
  • B(-OC (CH3) 2 C(CH3) 2 0-) or BF3K) can be reacted with the compounds of formula 1 1 under Suzuki cross-coupling conditions as mentioned in the scheme 7 to obtain compounds of formula I-Q2-A to I-Q1 -C.
  • Such transformation is usually carried out in the presence of Pd (for example complexes such as Pd(OAc) 2 or Pd 2 (dba)3) and a ligand.
  • Typical ligands may be mono- or bi- dentate, and include PP i3, PCV3, Pt-Bu3, x-phos, xantphos, s-phos, and dppf.
  • Suitable bases include carbonates such as sodium carbonate or cesium carbonate, phosphates such as potassium triphosphate, amines such as ethyldiisopropylamine or alkoxides such as sodium ter- butoxide.
  • Typical solvents include tetrahydrofuran, dioxane, toluene, ethanol, dimethyl formamide, water or mixtures thereof. Typical reaction temperatures range from ambient temperature to the boiling point of the solvent.
  • the Suzuki reaction is known from the literature, for example J. P. Wolfe, J. S. Nakhla, the Suzuki Reaction in Name Reactions for
  • reaction mixtures are worked up in a customary manner, for example by mixing with water, separating the phases and, if appropriate, chromatographic purification of the crude products.
  • Some of the intermediates and end products are obtained in the form of colorless or slightly brownish viscous oils which are purified or freed from volatile components under reduced pressure and at moderately elevated temperature. If the intermediates and end products are obtained as solids, purification can also be carried out by recrystallization or digestion.
  • N-oxides may be prepared from the inventive compounds according to conventional oxidation methods, e. g. by treating compounds I with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(1 1 ), 1892-903, 1995); or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981 ) or oxone (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001 ).
  • the oxidation may lead to pure mono-N-oxides or to a mixture of different N-oxides, which can be separated by conventional methods such as chromatography.
  • compound(s) according to the invention comprises the compound(s) as defined herein as well as a stereoisomer, salt, tautomer or N-oxide thereof.
  • compound(s) of the present invention is to be understood as equivalent to the term “compound(s) according to the invention”, therefore also comprising a stereoisomer, salt, tautomer or N-oxide thereof.
  • composition(s) according to the invention or “composition(s) of the present invention” encompasses composition(s) comprising at least one compound of formula I according to the invention as defined above.
  • compositions of the invention are preferably agricultural or veterinary compositions.
  • the compounds according to the invention may have one or more centers of chirality, in which case they are present as mixtures of enantiomers or diastereomers.
  • the invention provides both the single pure enantiomers or pure diastereomers of the compounds according to the invention, and their mixtures and the use according to the invention of the pure enantiomers or pure diastereomers of the compounds according to the invention or their mixtures.
  • Suitable compounds according to the invention also include all possible geometrical stereoisomers (cis/trans isomers) and mixtures thereof. Cis/trans isomers may be present with respect to an alkene, carbon-nitrogen double-bond or amide group.
  • stereoisomer(s) encompasses both optical isomers, such as enantiomers or
  • the present invention relates to every possible stereoisomer of the compounds of formula I, i.e. to single enantiomers or diastereomers, as well as to mixtures thereof.
  • the compounds according to the invention may be amorphous or may exist in one or more different crystalline states (polymorphs) which may have different macroscopic properties such as stability or show different biological properties such as activities.
  • the present invention relates to amorphous and crystalline compounds according to the invention, mixtures of different crystalline states of the respective compounds according to the invention, as well as amorphous or crystalline salts thereof.
  • Salts of the compounds according to the invention are preferably agriculturally and/or veterinary acceptable salts, preferably agriculturally acceptable salts. They can be formed in a customary manner, e.g. by reacting the compound with an acid of the anion in question if the compounds according to the invention have a basic functionality or by reacting acidic
  • Veterinary and/or agriculturally useful salts of the compounds according to the invention encompass especially the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the pesticidal action of the compounds according to the invention.
  • Suitable cations are in particular the ions of the alkali metals, preferably Li, Na and K, of the alkaline earth metals, preferably Ca, Mg and Ba, and of the transition metals, preferably Mn, Cu, Zn and Fe, and also ammonium (NhV) and substituted ammonium in which one to four of the H atoms are replaced by Ci-C4-alkyl, Ci-C4-hydroxyalkyl, Ci-C4-alkoxy, Ci-C4-alkoxy-Ci-C4-alkyl, hydroxy-Ci-C4-alkoxy-Ci-C4-alkyl, phenyl or benzyl.
  • substituted ammonium ions comprise methylammonium, isopropylammonium, dimethylammonium, diisopropylammonium, trimethylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2- hydroxyethylammonium, 2-(2-hydroxyethoxy)ethyl-ammonium, bis(2-hydroxyethyl)ammonium, benzyltrimethylammonium and benzyltriethylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri(Ci-C4- alkyl)sulfoxonium.
  • Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting compounds according to the invention with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.
  • N-oxide includes any compound of the present invention which has at least one tertiary nitrogen atom that is oxidized to an N-oxide moiety.
  • the organic moieties mentioned in the above definitions of the variables are - like the term halogen - collective terms for individual listings of the individual group members.
  • the prefix C n - Cm indicates in each case the possible number of carbon atoms in the group.
  • halogen denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.
  • alkyl as used herein and in the alkyl moieties of alkylamino, alkylcarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl and alkoxyalkyl denotes in each case a straight-chain or branched alkyl group having usually from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, more preferably from 1 to 3 carbon atoms.
  • Examples of an alkyl group are CH3, C2H5, n-propyl, iso-propyl, n-butyl, 2-butyl, iso-butyl, tert-butyl, n-pentyl, 1 - methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1 -ethyl propyl, n-hexyl, 1 ,1 - dimethylpropyl, 1 ,2-dimethylpropyl, 1 -methylpentyl, 2-methylpentyl, 3-methylpentyl, 4- methylpentyl, 1 ,1 -dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3- dimethylbutyl, 3,3-dimethylbutyl, 1 -ethylbutyl, 2-ethylbutyl, 1 ,1
  • haloalkyl as used herein and in the haloalkyl moieties of haloalkylcarbonyl, haloalkoxycarbonyl, haloalkylthio, haloalkylsulfonyl, haloalkylsulfinyl, haloalkoxy and
  • haloalkoxyalkyl denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms, preferably from 1 to 4 carbon atoms, wherein the H atoms of this group are partially or fully replaced with halogen atoms.
  • Preferred haloalkyl moieties are selected from Ci-C4-haloalkyl, more preferably from Ci-C3-haloalkyl or Ci-C2-haloalkyl, in particular from Ci-C2-fluoroalkyl such as fluoromethyl, difluoromethyl, trifluoromethyl, 1 - fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, and the like.
  • alkoxy denotes in each case a straight-chain or branched alkyl group which is bonded via an oxygen atom and has usually from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms.
  • alkoxy group examples are methoxy, ethoxy, n-propoxy, iso-propoxy, n-butyloxy, 2-butyloxy, iso-butyloxy, tert.-butyloxy, and the like.
  • alkoxyalkyl refers to alkyl usually comprising 1 to 4, preferably 1 to 2 carbon atoms, wherein 1 carbon atom carries an alkoxy radical usually comprising 1 to 4, preferably 1 or 2 carbon atoms as defined above. Examples are CH2OCH3, CH2-OC2H5, 2- (methoxy)ethyl, and 2-(ethoxy)ethyl.
  • haloalkoxy denotes in each case a straight-chain or branched alkoxy group having from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, wherein the H atoms of this group are partially or fully replaced with halogen atoms, in particular fluorine atoms.
  • Ci-C4-haloalkoxy moieties include Ci-C4-haloalkoxy, in particular Ci-C2-fluoroalkoxy, such as fluoromethoxy, difluoromethoxy, trifluoromethoxy, 1 -fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoro-ethoxy, 2,2-dichloro-2-fluorethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and the like.
  • Ci-C4-haloalkoxy such as fluoromethoxy, difluoromethoxy, trifluoromethoxy, 1 -fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy
  • Examples include methylthio, ethylthio, propylthio, isopropylthio, and n-butylthio.
  • haloalkylthio refers to an alkylthio group as mentioned above wherein the H atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine. Examples include chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoromethylthio,
  • dichlorofluoromethylthio chlorodifluoromethylthio, 1 -chloroethylthio, 1 -bromoethylthio, 1 - fluoroethylthio, 2-fluoroethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2- fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2- trichloroethylthio and pentafluoroethylthio and the like.
  • alkoxycarbonyl refers to an alkylcarbonyl group as defined above, which is bonded via an oxygen atom to the remainder of the molecule.
  • alkenyl denotes in each case a singly unsaturated hydrocarbon radical having usually 2 to 6, preferably 2 to 4 carbon atoms, wherein the double bond may be present in any position, e.g. vinyl, allyl (2-propen-1-yl), 1 -propen-1 -yl, 2-propen-2-yl, methallyl (2-methylprop-2-en-1 -yl), 2-buten-1 -yl, 3-buten-1 -yl, 2-penten-1 -yl, 3-penten-1 -yl, 4-penten-1 -yl, 1 -methylbut-2-en-1 -yl, 2-ethylprop-2-en-1 -yl and the like.
  • haloalkenyl refers to an alkenyl group as defined above, wherein the H atoms are partially or fully replaced with halogen atoms.
  • alkynyl denotes in each case a singly unsaturated hydrocarbon radical having usually 2 to 6, preferably 2 to 4 carbon atoms, wherein the triple bond may be present in any position, e.g. ethynyl, propargyl (2-propyn-1 -yl), 1 -propyn-1 -yl, 1 -methylprop-2- yn-1 -yl), 2-butyn-1 -yl, 3-butyn-1 -yl, 1 -pentyn-1 -yl, 3-pentyn-1 -yl, 4-pentyn-1 -yl, 1 -methylbut-2- yn-1 -yl, 1 -ethylprop-2-yn-1 -yl and the like.
  • haloalkynyl refers to an alkynyl group as defined above, wherein the H atoms are partially or fully replaced with halogen atoms.
  • cycloalkyl as used herein and in the cycloalkyl moieties of cycloalkoxy and cycloalkylthio denotes in each case a monocyclic cydoaliphatic radical having usually from 3 to 8 or from 3 to 6 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl or cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • halocycloalkyl as used herein and in the halocycloalkyl moieties of halocycloalkoxy and halocycloalkylthio denotes in each case a monocyclic cydoaliphatic radical having usually from 3 to 8 C atoms or 3 to 6 C atoms, wherein at least one, e.g. 1 , 2, 3, 4 or 5 of the H atoms, are replaced by halogen, in particular by fluorine or chlorine.
  • Examples are 1 - and 2- fluorocyclopropyl, 1 ,2-, 2,2- and 2,3-difluorocyclopropyl, 1 ,2,2-trifluorocyclopropyl, 2,2,3,3- tetrafluorocyclpropyl, 1 - and 2-chlorocyclopropyl, 1 ,2-, 2,2- and 2,3-dichlorocyclopropyl, 1 ,2,2- trichlorocyclopropyl, 2,2,3,3-tetrachlorocyclpropyl, 1 -,2- and 3-fluorocyclopentyl, 1 ,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1 -,2- and 3-chlorocyclopentyl, 1 ,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1 -,2- and 3-chlorocyclopentyl, 1
  • cycloalkenyl as used herein and in the cycloalkenyl moieties of cycloalkenyloxy and cycloalkenylthio denotes in each case a monocyclic singly unsaturated non-aromatic radical having usually from 3 to 8, e.g. 3 or 4 or from 5 to 10 carbon atoms, preferably from 3- to 8 carbon atoms.
  • exemplary cycloalkenyl groups include cyclopropenyl, cycloheptenyl or cyclooctenyl.
  • substituted refers to substitued with 1 , 2, 3 or up to the maximum possible number of substituents. If substituents as defined in compounds of formula I are more than one then they are independently from each other are same or different if not mentioned otherwise.
  • carrier or “carbocyclyl” includes, unless otherwise indicated, in general a 3- to 12-membered, preferably a 3- to 8-membered or a 5- to 8-membered, more preferably a 5- or 6- membered mono-cyclic, non-aromatic ring comprising 3 to 12, preferably 3 to 8 or 5 to 8, more preferably 5 or 6 carbon atoms.
  • the term “carbocycle” covers cycloalkyl and cycloalkenyl groups as defined above, for example cyclopropane, cyclobutane, cyclopentane and cyclohexane rings.
  • heterocycle or “heterocyclyl” includes, unless otherwise indicated, in general 3- to 10-membered, preferably 3- to 8-membered or 5- to 8-membered, more preferably 5- or 6- membered, in particular 6-membered monocyclic heterocyclic non-aromatic radicals.
  • the heterocyclic non-aromatic radicals usually comprise 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3 heteroatoms selected from N, O and S as ring members, where S-atoms as ring members may be present as S, SO or SO2. If not mentioned contrary, the N and S atoms of the heterocycle can be oxidized.
  • Examples of 5- or 6-membered heterocyclic radicals comprise saturated or unsaturated, non-aromatic heterocyclic rings, such as oxiranyl, oxetanyl, thietanyl, thietanyl-S- oxid (S-oxothietanyl), thietanyl-S-dioxid (S-dioxothiethanyl), pyrrolidinyl, pyrrolinyl, pyrazolinyl, tetrahydrofuranyl, dihydrofuranyl, 1 ,3-dioxolanyl, thiolanyl, S-oxothiolanyl, S-dioxothiolanyl, dihydrothienyl, S-oxodihydrothienyl, S-dioxodihydrothienyl, oxazolidinyl, oxazolinyl, thiazolinyl, ox
  • heterocyclic ring refers to heterocycle which is partially unsaturated or heterocycle which is fully unsaturated.
  • Partially unsaturated heterocycle includes monocyclic 3- or 6-membered partially unsaturated heterocyclic radicals comprising as ring members 1 , 2, 3 or 4 heteroatoms selected from N, O and S.
  • 3- to 6-membered partially unsaturated heterocycles include azirine, oxeteen, dihydropyrol, dihydrofuran, dihydrothiophene, dihydrooxazole,
  • Fully unsaturated heterocycle includes monocyclic 5- or 6-membered fully unsaturated heterocyclic radicals comprising as ring members 1 , 2, 3 or 4 heteroatoms selected from N, O and S.
  • Examples of 5- or 6-membered fully unsaturated heterocycles include pyridyl, i.e. 2-, 3-, or 4-pyridyl, pyrimidinyl, i.e. 2-, 4- or 5-pyrimidinyl, pyrazinyl, pyridazinyl, i.e. 3- or 4-pyridazinyl, thienyl, i.e.
  • oxadiazolyl e.g. 2- or 5-[1 ,3,4]oxadiazolyl, 4- or 5-(1 ,2,3-oxadiazol)yl, 3- or 5-(1 ,2,4-oxadiazol)yl, 2- or 5-(1 ,3,4-thiadiazol)yl, thiadiazolyl, e.g. 2- or 5-(1 ,3,4-thiadiazol)yl, 4- or 5-(1 ,2,3-thiadiazol)yl, 3- or 5-(1 ,2,4-thiadiazol)yl, triazolyl, e.g.
  • partially or fully unsaturated heterocycle or “partially or fully unsaturated heterocyclic ring” also includes bicyclic 8 to 10-membered partially or fully unsaturated heterocyclic radicals comprising as ring members 1 , 2 or 3 heteroatoms selected from N, O and S, wherein a 5- or 6-membered hetercyclic ring is fused to a phenyl ring or to a 5- or 6-membered heteroaromatic radical.
  • Examples of a 5- or 6-membered heteroaromatic ring fused to a phenyl ring or to a 5- or 6- membered heteroaromatic radical include benzofuranyl, benzothienyl, indolyl, indazolyl, benzimidazolyl, benzoxathiazolyl, benzoxadiazolyl, benzothiadiazolyl, benzoxazinyl, chinolinyl, isochinolinyl, purinyl, 1 ,8-naphthyridyl, pteridyl, pyrido[3,2-d]pyrimidyl or pyridoimidazolyl and the like.
  • These fused hetaryl radicals may be bonded to the remainder of the molecule via any ring atom of 5- or 6-membered heteroaromatic ring or via a carbon atom of the fused phenyl moiety.
  • alkylene alkenylene, and alkynylene refer to alkyl, alkenyl, and alkynyl as defined above, respectively, which are bonded to the remainder of the molecule, via two atoms, preferably via two carbon atoms, of the respective group, so that they represent a linker between two moieties of the molecule.
  • alkylene may refer to alkyl chains such as -CH 2 CH 2 -,
  • alkenylene and alkynylene may refer to alkenyl and alkynyl chains, respectively.
  • CN refers to cyano group
  • A is N or CR 1 .
  • B is N or CR 1 .
  • Particular embodiments of the compounds I are the following compounds I .A, I.B and I.C.
  • the substituents R 1 is independently as defined or preferably defined herein:
  • Q is Q1 or Q2;
  • X is CR A
  • A is CR 1
  • B is N.
  • X is N
  • A is CR 1 and B is N.
  • X is CR A , A is N and B is CR 1 .
  • X is N
  • A is N
  • B is CR 1 .
  • X is CR A
  • A is CR 1
  • B is CR 1 .
  • X is N, A is CR 1 and B is CR 1 .
  • X is CH, A is CH and B is N. In still another embodiment of formula I, X is N, A is CH and B is N.
  • X is CH, A is N and B is CH.
  • X is CH
  • A is CH
  • B is CH
  • X is N, A is CH and B is CH.
  • R 1 is H, halogen, CN, NO2, Ci-C4-alkyl, C1-C4- haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio.
  • R 1 is H or halogen such as CI, Br, F, and I.
  • R 1 is CN or NO2.
  • R 1 is selected from H, Ci-C4-alkyl and Ci-C4-haloalkyl. In still another embodiment of formula I, R 1 is H.
  • R 1 is selected from Ci-C4-alkoxy and C1-C4- haloalkoxy.
  • R 1 is selected from Ci-C4-alkylthio, C1-C4- haloalkylthio, S(0)-Ci-C 4 alkyl and S(0) 2 -Ci-C 4 alkyl.
  • R 1 is H or Ci-C4-alkyl, such as CH3, C2H5, n-propyl, i- propyl, n-butyl, i-butyl, and tert-butyl.
  • R 1 is Ci-C4-alkyl, such as CH3, C2H5, n-propyl, i- propyl, n-butyl, i-butyl, and tert-butyl.
  • R 1 is H or Ci-C4-haloalkyl, in particular H, or C1-C2- haloalkyl, such as H, CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2 or CF 2 CHF 2 .
  • R 1 is Ci-C4-haloalkyl, in particular H, or C1-C2- haloalkyl, such as H, CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2, or CF 2 CHF 2 .
  • R 1 is H, or is Ci-C4-alkoxy, more specifically C1-C2- alkoxy such as OCH 3 , or OCH2CH3.
  • R 1 is Ci-C4-alkoxy, more specifically Ci-C2-alkoxy such as OCH3, or OCH2CH3.
  • R 1 is Ci-C4-haloalkoxy, more specifically Ci-C2-halo- alkoxy such as OCF 3 , OCHF 2 , OCH 2 F, OCCI 3 , OCHC , or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCI3, or OCHCb.
  • R 1 is Ci-C4-alkylthio, Ci-C4-haloalkylthio; S(0)-Ci-C4- alkyl, S(0) 2 -Ci-C 4 -alkyl.
  • R 1 is Ci-C4-alkylthio or Ci-C4-haloalkylthio such as SCH 3 , SCH2CH3, or SCF 3 , SCCI3, SCH 2 F, SCH2CI, SCHF 2 respectively.
  • Q is Q1 ; wherein X is N or CR A and Yi, Y2 and Y3 are each independently C, N or NR 2A ; and together forms annulated saturated, partially or fully unsaturated ring.
  • Q is Q1 ; wherein X is N and Yi, Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y3 are each independently C or N and Y2 is NR 2A or C.
  • Q is Q1 ; wherein X is N and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y2 are each independently C or N and Y3 is NR 2A or C.
  • Q is Q1 ; wherein X is CR A and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y3 are each independently C or N and Y2 is NR 2A or C.
  • Q is Q1 ; wherein X is CR A and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y2 are each independently C or N and Y3 is NR 2A or C.
  • Q is Q1 and is selected from Q1 -A to Q1 -L as shown below,
  • $ denotes the bond to the pyridine ring of formula I .A or I.B, and wherein
  • R A , R 2 and R 2A are as defined in formula I above, and wherein m is 0, 1 or 2.
  • Q is Q2; wherein X is N or CR A and Yi , Y2 and Y3 are each independently C, N or NR 2A ; and together forms annulated saturated, partially or fully unsaturated ring.
  • Q is Q2; wherein X is N and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y3 are each independently C or N and Y2 is NR 2A or C.
  • Q is Q2; wherein X is N and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y2 are each independently C or N and Y3 is NR 2A or C.
  • Q is Q2; wherein X is CR A and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y3 are each independently C or N and Y2 is NR 2A or C.
  • Q is Q2; wherein X is CR A and Yi , Y2 and Y3 together forms an unsaturated ring; wherein Yi and Y2 are each independently C or N and Y3 is NR 2A or C.
  • Q is Q2 and is selected from Q2-A to Q2-F below,
  • $ denotes the bond to the pyridine ring of formula I .A, I.B, I.C, I.D and I.E and wherein m is 0, 1 or 2 and R A and R 2 are as defined in formula I above.
  • R A is selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy, Ci-C 4 -haloalkoxy, Ci-C 4 -alkylthio, or Ci-C 4 -haloalkylthio; S(O) Ci-C 4 alkyl, S(0) 2 Ci-C 4 alkyl, C(0)NHR B .
  • R A is selected from H, Ci-C4-alkyl, and Ci-C4-haloalkyl.
  • R A is selected from Ci-C4-alkoxy, and C1-C4- haloalkoxy,
  • R A is selected from Ci-C4-alkylthio, C1-C4- haloalkylthio, S(0)Ci-C 4 -alkyl and S(0) 2 Ci-C 4 -alkyl.
  • R A is selected from H, Ci-C4-alkyl, and C(0)NHR B . In still another embodiment of formula I, R A is H.
  • R A is H or Ci-C4-alkyl, such as H, CH3, C2H5, n-propyl, i-propyl, n-butyl, i-butyl, and tert-butyl.
  • R A is Ci-C4-alkyl, such as H, CH3, C2H5, n-propyl, i- propyl, n-butyl, i-butyl, and tert-butyl.
  • R A is H or Ci-C4-haloalkyl, in particular H or C1-C2- haloalkyl, such as H, CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2, or CF 2 CHF 2 .
  • R A is Ci-C4-haloalkyl, in particular H or Ci-C2-halo- alkyl, such as H, CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2, or CF 2 CHF 2 .
  • R A is H or is Ci-C4-alkoxy, more specifically C1-C2- alkoxy such as OCH 3 , or OCH2CH3.
  • R A is Ci-C4-alkoxy, more specifically Ci-C2-alkoxy such as OCH3, or OCH2CH3.
  • R A is Ci-C4-haloalkoxy, more specifically Ci-C2-halo- alkoxy such as OCF 3 , OCHF 2 , OCH 2 F, OCCI 3 , OCHC , or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCIs or OCHCb.
  • R A is Ci-C4-alkylthio, Ci-C4-haloalkylthio; S(0)Ci-C 4 - alkyl, S(0) 2 Ci-C 4 -alkyl.
  • R A is Ci-C4-alkylthio or Ci-C4-haloalkylthio such as SCHs, SCH2CH3, or SCFs, SCCI3, SCH 2 F, SCH2CI, SCHF 2 respectively.
  • R A is S(O) Ci-C 4 -alkyl, S(0)2Ci-C4-alkyl such as S(0)CH 3 , S(0)CH 2 CH 3 , or S(0) 2 CH 3 , S(0) 2 CH 2 CH 3 respectively.
  • R A is selected from H or C(0)NHR B , wherein R B is as defined above or defined herein.
  • R A is selected from H, C(0)NH CH 3 , C(0)NH CH 2 CH 3 , C(0)NH phenyl, C(0)NH heteroaromatic; wherein the heteroaromatic ring comprises 1 , 2 or 3 heteroatoms selected from O, N and S; and wherein the phenyl or the heteroaromatic ring is unsubstituted or substituted with substituents selected from the group consisting of halogen, N0 2 , CN, OH, SH, C1-C4 alkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 4 -alkylthio, C1-C4- alkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C6-haloalkylthio, trimethylsilyl, triethylsilyl, and tert- butyldimethylsilyl.
  • R B is Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C 4 -alkylthio, Ci-C 4 -haloalkylthio; S(0)Ci-C 4 -alkyl, S(0) 2 Ci-C 4 -alkyl, phenyl, or a 5-, 6-, 7-, 8- or 9-membered heterocyclic or heteroaromatic ring comprising 1 , 2 or 3
  • heteroatoms selected from O, N and S wherein the phenyl, heterocyclic or heteroaromatic rings are unsubstituted or substituted with substituents selected from the group consisting of halogen, N0 2 , CN, OH, SH, Ci-C 4 -alkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 4 -alkylthio, C1-C4- alkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C6-haloalkylthio, trimethylsilyl, triethylsilyl, and tert- butyldimethylsilyl;
  • R B is selected from H, Ci-C4-alkyl, and Ci-C4-haloalkyl.
  • R B is selected from Ci-C4-alkoxy, and C1-C4- haloalkoxy,
  • R B is selected from Ci-C4-alkylthio, C1-C4- haloalkylthio, S(0)Ci-C 4 -alkyl and S(0) 2 Ci-C 4 -alkyl.
  • R B is selected from H, Ci-C4-alkyl, and C(0)NHR B .
  • R B is H.
  • R B is H or Ci-C4-alkyl, such as H, CH 3 , C2H5, n-propyl, i-propyl, n-butyl, i-butyl, and tert-butyl.
  • R B is Ci-C4-alkyl, such as H, CH 3 , C2H5, n-propyl, i- propyl, n-butyl, i-butyl, and tert-butyl.
  • R B is H or Ci-C4-haloalkyl, in particular H or Ci-C2- haloalkyl, such as H, CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF 3 CH 2 , CCI 3 CH 2 , or CF 2 CHF 2 .
  • R B is Ci-C4-haloalkyl, in particular H or Ci-C2-halo- alkyl, such as H, CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF 3 CH 2 , CCI 3 CH 2 , or CF 2 CHF 2 .
  • R B is H or is Ci-C4-alkoxy, more specifically C1-C2- alkoxy such as OCH 3 , or OCH2CH3.
  • R B is Ci-C4-alkoxy, more specifically Ci-C2-alkoxy such as OCH3, or OCH2CH3.
  • R B is Ci-C4-haloalkoxy, more specifically Ci-C2-halo- alkoxy such as OCF 3 , OCHF 2 , OCH 2 F, OCCI 3 , OCHC , or OCH 2 CI, in particular OCF 3 , OCHF 2 , OCCI3, or OCHCb.
  • R B is Ci-C4-alkylthio, Ci-C4-haloalkylthio; S(0)Ci-C 4 - alkyl, S(0) 2 Ci-C 4 -alkyl.
  • R B is C1-C4 alkylthio or C1-C4 haloalkylthio such as SCH 3 , SCH2CH3, or SCF 3 , SCCI3, SCH 2 F, SCH2CI, SCHF 2 respectively.
  • R B is S(0)Ci-C4 alkyl, S(0)2Ci-C4-alkyl
  • R B is phenyl or a 5-, 6-, 7-, 8- or 9-membered heterocyclic or heteroaromatic ring comprising 1 , 2 or 3 heteroatoms selected from O, N and S; wherein the phenyl, heterocyclic or heteroaromatic rings are unsubstituted or substituted with substituents selected from the group consisting of halogen, NO2, CN, OH, SH, Ci-C 4 -alkyl, Ci- C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 4 -alkylthio, Ci-C 4 -alkylsulfinyl, Ci-C 4 -alkylsulfonyl, C1-C6- haloalkylthio, trimethylsilyl, triethylsilyl, and tert-butyldimethylsilyl.
  • heterocyclic ring comprises 1 , 2 or 3 heteroatoms independently selected from the group consisting of O, N, and S, and is unsubstituted or substituted with substituents R 14 , said substituents R 14 being identical or different from one another if more than one substituent R 14 is present, and wherein said N and S atoms, independently of one another, may be oxidized;
  • R 12 , R 13a , R 13b , R 14 , R 15 and R 16 are as already defined hereinabove.
  • R 2 is selected from halogen, CN, NO2, Ci-Cio-alkyl and Ci-C4-halo-alkyl.
  • R 2 is selected from Br, CI, F, I, CN, CH3, C2H5, n- propyl, i-propyl, n-butyl, i-butyl and tert-butyl, OCH 3 , or OCH 2 CH 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, C CH, CF3CH2, and CCI3CH2.
  • R 2 is Ci-C4-alkylthio or Ci-C4-haloalkylthio such as SCH 3 , SCH 2 CH 3 , or SCF 3 , SCCI3, SCH 2 F, SCH 2 CI, SCHF 2 respectively.
  • R 2 is selected from S(0)CH3, S(0)CH2CH3 or S(0) 2 CH 3 , and S(0) 2 CH 2 CH 3 .
  • R 2 is 3-, 4-, 5-, 6- or 7-membered saturated, partially or fully unsaturated heterocyclic ring wherein said heterocyclic ring comprises 1 , 2 or 3 heteroatoms independently selected from the group consisting of O, N, and S, and is
  • substituents R 14 unsubstituted or substituted with substituents R 14 , said substituents R 14 being identical or different from one another if more than one substituent R 14 is present, and wherein said N and S atoms, independently of one another, may be oxidized;
  • R 2 is not halogen, if R 2 is bonded to a heteroatom.
  • R 2 is a substituent
  • ⁇ denotes the bond to the atom on which R 2 is present
  • X is NR 3 , O or S
  • R 4 is H, CR 5 R 6 R 7 , NR 8 R 9 , OR 10 , or SR 10 ;
  • R 3 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are as already defined hereinabove.
  • m is 0.
  • m is 1.
  • m is 2.
  • R 2A is H.
  • cycloaliphatic radicals each independently are unsubstituted or substituted with substituents R 11 , said substituents R 11 being identical or different from one another if more than one substituent R 11 is present;
  • heterocyclic ring comprises 1 , 2 or 3 heteroatoms independently selected from the group consisting of O, N, and S, and unsubstituted or substituted with substituents R 14 , said substituents R 14 being identical or different from one another if more than one substituent R 14 is present, and wherein said N and S atoms, independently of one another, may be oxidized; with the proviso that R 2 is not halogen, if R 2 is bonded to a heteroatom;
  • R 12 , R 13a , R 13b , R 14 , R 15 and R 16 are as already defined hereinabove.
  • R 2A is selected from Ci-Cio-alkyl and Ci-C4-haloalkyl.
  • R 2A is selected from CH3, C2H5, n-propyl, i-propyl, n- butyl, i-butyl and tert-butyl, OCH 3 , or OCH 2 CH 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, and
  • R 2A is Ci-C4-alkylthio or Ci-C4-haloalkylthio such as SCH 3 , SCH2CH3 or SCF 3 , SCCI3, SCH 2 F, SCH2CI, SCHF 2 respectively.
  • R 2 is selected from S(0)CH 3 , S(0)CH 2 CH 3 , S(0) 2 CH 3 , and S(0) 2 CH 2 CH 3 .
  • R 2A is 3-, 4-, 5-, 6- or 7-membered saturated, partially or fully unsaturated heterocyclic ring wherein said heterocyclic ring comprises 1 , 2 or 3 heteroatoms independently selected from the group consisting of O, N, and S, and is
  • substituents R 14 unsubstituted or substituted with substituents R 14 , said substituents R 14 being identical or different from one another if more than one substituent R 14 is present, and wherein said N and S atoms, independently of one another, may be oxidized;
  • R 2 is not halogen, if R 2A is bonded to a heteroatom.
  • R 2A is a substituent R2-1 as defined in outset.
  • variables of the compounds of the formula I have the following meanings, these meanings, both on their own and in combination with one another, being particular embodiments of the compounds of the formula I:
  • Preferred embodiment of the present invention are the following compounds of formula I.Q1 .A, I.Q1.B, I.Q1 .C, I.Q1 .D, I.Q1.E and I.Q1.F.
  • m in each of the formulae I.Q1 .A, I.Q1 .B, I.Q1 .C, I.Q1 .D, I.Q1 .E and I.Q1.F respectively is 0, i.e. the heteroaryl is not substituted.
  • These compounds are named I.Q1.A.1 , I.Q1.B.1 , I.Q1.C.1 , I.Q1.D.1 , I.Q1.E.1 and I.Q1.F.1 , respectively.
  • compounds of the invention are the compounds of the formulae I.Q1 .A, I.Q1.B, I.Q1 .C, I.Q1.D, I.Q1.E and I.Q1.F that are compiled in the Tables 1 -1 to 1 -8, Tables 2-1 to 2-8, Tables 3-1 to 3-8, Tables 4-1 to 4- 8, Tables 5-1 to 5-8 and Tables 6-1 to 6-8.
  • Substituents defined for R 2 includes below groups P1 to P3.
  • # denotes the bond to the atom, on which R 2 is present.
  • Table 1 -1 Compounds of formula I.Q1.A in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -2 Compounds of formula I.Q1.A in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -3 Compounds of formula I.Q1.A in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -4 Compounds of formula I.Q1.A in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -5 Compounds of formula I.Q1.A in which m is 1 , R 2 is "2-CH3, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -6 Compounds of formula I.Q1.A in which m is 1 , R 2 is "2-P1 , A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -7 Compounds of formula I.Q1.A in which m is 1 , R 2 is "2-P2, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 1 -8 Compounds of formula I.Q1.A in which m is 1 , R 2 is "2- P3, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 2-1 Compounds of formula I.Q1 .B in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 2-2 Compounds of formula I.Q1 .B in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 2-4 Compounds of formula I.Q1 .B in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 2-7 Compounds of formula I.Q1 .B in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 2-8 Compounds of formula I.Q1 .B in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-1 Compounds of formula I.Q1 .C in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-2 Compounds of formula I.Q1 .C in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-3 Compounds of formula I.Q1 .C in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-4 Compounds of formula I.Q1 .C in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-5 Compounds of formula I.Q1 .C in which m is 1 , R 2 is "2-CH3, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-6 Compounds of formula I.Q1 .C in which m is 1 , R 2 is "2-P1 , A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-7 Compounds of formula I.Q1 .C in which m is 1 , R 2 is "2-P2, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 3-8 Compounds of formula I.Q1 .C in which m is 1 , R 2 is "2-P3, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 4-1 Compounds of formula I.Q1 .D in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 4-2 Compounds of formula I.Q1 .D in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 4-3 Compounds of formula I.Q1 .D in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 4-4 Compounds of formula I.Q1 .D in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 4-7 Compounds of formula I.Q1 .D in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 4-8 Compounds of formula I.Q1 .D in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 5-1 Compounds of formula I.Q1 .E in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 5-2 Compounds of formula I.Q1 .E in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 5-3 Compounds of formula I.Q1 .E in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 5-4 Compounds of formula I.Q1.E in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 5-8 Compounds of formula I.Q1 .E in which m is 1 , R 2 is - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 6-1 Compounds of formula I.Q1 .F in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 6-2 Compounds of formula I.Q1 .F in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 6-3 Compounds of formula I.Q1 .F in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 6-4 Compounds of formula I.Q1 .F in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • Table 6-8 Compounds of formula I.Q1 .F in which m is 1 , R 2 is "3-P3, A is CH, B is CR 1 and the meaning for the combination of R 1 , R 2A and R A for each individual compound corresponds in each case to one line of Table A.
  • compounds of the invention are the compounds of the formulae I.Q1 .G, I.Q1.H, I.Q1 .1, I.Q1.J, I.Q1.K and I.Q1.L that are compiled in the Tables 7-1 to 7-8, Tables 8-1 to 8-8, Tables 9-1 to 9-8, Tables 10-1 to 10-8, Tables 1 1 -1 to 1 1 -8 and Tables 12-1 to 12-8.
  • Table 7-1 Compounds of formula I.Q1 .G in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 7-2 Compounds of formula I.Q1 .G in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 7-3 Compounds of formula I.Q1 .G in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 7-4 Compounds of formula I.Q1 .G in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 7-6 Compounds of formula I.Q1 .G in which m is 1 , R 2 is "2- P1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 7-7 Compounds of formula I.Q1 .G in which m is 1 , R 2 is "2-P2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 7-8 Compounds of formula I.Q1 .G in which m is 1 , R 2 is "2-P3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-1 Compounds of formula I.Q1 .H in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-2 Compounds of formula I.Q1 .H in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-3 Compounds of formula I.Q1 .H in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-4 Compounds of formula I.Q1.H in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-5 Compounds of formula I.Q1 .H in which m is 1 , R 2 is "2-CH3, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-6 Compounds of formula I.Q1 .H in which m is 1 , R 2 is "2-P1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-7 Compounds of formula I.Q1 .H in which m is 1 , R 2 is "2-P2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 8-8 Compounds of formula I.Q1 .H in which m is 1 , R 2 is "2-P3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 9-1 Compounds of formula I.Q1 .1 in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 9-2 Compounds of formula I.Q1 .1 in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 9-4 Compounds of formula I.Q1 .1 in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 9-7 Compounds of formula I.Q1 .I in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 9-8 Compounds of formula I.Q1 .I in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-1 Compounds of formula I.Q1 .J in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-2 Compounds of formula I.Q1 J in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-3 Compounds of formula I.Q1 J in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-4 Compounds of formula I.Q1 J in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-6 Compounds of formula I.Q1 .J in which m is 1 , R 2 is "1 - P1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-7 Compounds of formula I.Q1 .J in which m is 1 , R 2 is - ⁇ 1 , A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 10-8 Compounds of formula I.Q1 .J in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -1 Compounds of formula I.Q1 .K in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -2 Compounds of formula I.Q1 .K in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -3 Compounds of formula I.Q1 .K in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -4 Compounds of formula I.Q1 .K in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -5 Compounds of formula I.Q1 .K in which m is 1 , R 2 is "2-CH3, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -6 Compounds of formula I.Q1 .K in which m is 1 , R 2 is "2- P1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -7 Compounds of formula I.Q1 .K in which m is 1 , R 2 is "2-P2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 1 1 -8 Compounds of formula I.Q1 .K in which m is 1 , R 2 is "2-P3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-1 Compounds of formula I.Q1 .L in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-2 Compounds of formula I.Q1 .L in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-3 Compounds of formula I.Q1 .L in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-4 Compounds of formula I.Q1 .L in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-6 Compounds of formula I.Q1 .L in which m is 1 , R 2 is "3-P1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-7 Compounds of formula I.Q1 .L in which m is 1 , R 2 is "3-P2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • Table 12-8 Compounds of formula I.Q1 .L in which m is 1 , R 2 is "3-P3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R 2A for each individual compound corresponds in each case to one line of Table B.
  • compounds of the invention are the compounds of the formulae I.Q2.A, I.Q2.B and I.Q2.C that are compiled in the Tables 13-1 to 13-8, Tables 14-1 to 14-8 and Tables 15-1 to 15-8.
  • Table 13-1 Compounds of formula I.Q2.A in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-2 Compounds of formula I.Q2.A in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-3 Compounds of formula I.Q2.A in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-4 Compounds of formula I.Q2.A in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-5 Compounds of formula I.Q2.A in which m is 1 , R 2 is "1 -CH 3 , A is N, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-6 Compounds of formula I.Q2.A in which m is 1 , R 2 is "1 - P1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-7 Compounds of formula I.Q2.A in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 13-8 Compounds of formula I.Q2.A in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 14-1 Compounds of formula I.Q2.B in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 14-2 Compounds of formula I.Q2.B in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 14-3 Compounds of formula I.Q2.B in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 14-4 Compounds of formula I.Q2.B in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 14-7 Compounds of formula I.Q2.B in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 14-8 Compounds of formula I.Q2.B in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-1 Compounds of formula I.Q2.C in which m is 0, A is N, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-2 Compounds of formula I.Q2.C in which m is 0, A is CR 1 , B is N and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-3 Compounds of formula I.Q2.C in which m is 0, A is CR 1 , B is CH and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-4 Compounds of formula I.Q2.C in which m is 0, A is CH, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-6 Compounds of formula I.Q2.C in which m is 1 , R 2 is - ⁇ 1 , A is CR 1 , B is N and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-7 Compounds of formula I.Q2.C in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Table 15-8 Compounds of formula I.Q2.C in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning for the combination of R 1 and R A for each individual compound corresponds in each case to one line of Table C.
  • Preferred compounds of the invention are the compounds of the formulae I.Q2.A, I.Q2.B and I.Q2.C that are compiled in the Tables 16-1 to 16-8, Tables 17-1 to 17-8, and Tables 18-1 to 18- 8.
  • Table 16-1 Compounds of formula I.Q2.D in which m is 0, A is N, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 16-2 Compounds of formula I.Q2.D in which m is 0, A is CR 1 , B is N and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 16-3 Compounds of formula I.Q2.D in which m is 0, A is CR 1 , B is CH and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 16-4 Compounds of formula I.Q2.D in which m is 0, A is CH, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 16-7 Compounds of formula I.Q2.D in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 16-8 Compounds of formula I.Q2.D in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-1 Compounds of formula I.Q2.E in which m is 0, A is N, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-2 Compounds of formula I.Q2.E in which m is 0, A is CR 1 , B is N and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-3 Compounds of formula I.Q2.E in which m is 0, A is CR 1 , B is CH and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-4 Compounds of formula I.Q2.E in which m is 0, A is CH, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-6 Compounds of formula I.Q2.E in which m is 1 , R 2 is "1 - P1 , A is CR 1 , B is N and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-7 Compounds of formula I.Q2.E in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 17-8 Compounds of formula I.Q2.E in which m is 1 , R 2 is ⁇ - ⁇ 3, A is CH, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 18-1 Compounds of formula I.Q2.F in which m is 0, A is N, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 18-2 Compounds of formula I.Q2.F in which m is 0, A is CR 1 , B is N and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 18-4 Compounds of formula I.Q2.F in which m is 0, A is CH, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 18-7 Compounds of formula I.Q2.F in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CR 1 , B is CH and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • Table 18-8 Compounds of formula I.Q2.F in which m is 1 , R 2 is ⁇ - ⁇ 2, A is CH, B is CR 1 and the meaning of R 1 for each individual compound corresponds in each case to one line of Table D.
  • the term "compound(s) of the present invention” or “compound(s) according to the invention” refers to the compound(s) of formula (I) as defined above, which are also referred to as “compound(s) of formula I” or “compound(s) I” or “formula I compound(s)”, and includes their salts, tautomers, stereoisomers, and N-oxides.
  • the present invention also relates to a mixture of at least one compound of the present invention with at least one mixing partner as defined herein after.
  • Preferred are binary mixtures of one compound of the present invention as component I with one mixing partner as defined herein after as component II.
  • Preferred weight ratios for such binary mixtures are from 5000:1 to
  • components I and II may be used in equal amounts, or an excess of component I, or an excess of component II may be used.
  • Mixing partners can be selected from pesticides, in particular insecticides, nematicides, and acaricides, fungicides, herbicides, plant growth regulators, fertilizers, and the like.
  • Preferred mixing partners are insecticides, nematicides and fungicides.
  • M.1 Acetylcholine esterase (AChE) inhibitors from the class of: M.1 A carbamates, for example aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; or from the class of M.1 B organo
  • GABA-gated chloride channel antagonists such as: M.2A cyclodiene organochlorine compounds, as for example endosulfan or chlordane; or M.2B fiproles (phenylpyrazoles), as for example ethiprole, fipronil, flufiprole, pyrafluprole and pyriprole;
  • M.3 Sodium channel modulators from the class of M.3A pyrethroids for example acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S- cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda- cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta- cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fen
  • M.3B sodium channel modulators such as DDT or methoxychlor
  • M.4 Nicotinic acetylcholine receptor agonists from the class of M.4A neonicotinoids, for example acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or the compounds M.4A.2: (2E-)-1 -[(6-Chloropyridin-3-yl)methyl]- N'-nitro-2-pentylidenehydrazinecarboximidamide; or M4.A.3: 1 -[(6-Chloropyridin-3-yl)methyl]-7- methyl-8-nitro-5-propoxy-1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridine; or from the class M.4B nicotine;
  • M.6 Chloride channel activators from the class of avermectins and milbemycins, for example abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
  • M.7 Juvenile hormone mimics such as M.7A juvenile hormone analogues as hydroprene, kinoprene and methoprene; or others as M.7B fenoxycarb or M.7C pyriproxyfen; M.8 miscellaneous non-specific (multi-site) inhibitors, for example M.8A alkyl halides as methyl bromide and other alkyl halides, or M.8B chloropicrin, or M.8C sulfuryl fluoride, or M.8D borax, or M.8E tartar emetic;
  • M.8A alkyl halides as methyl bromide and other alkyl halides
  • M.8B chloropicrin or M.8C sulfuryl fluoride
  • M.8D borax or M.8E tartar emetic
  • M.9 Selective homopteran feeding blockers for example M.9B pymetrozine, or M.9C flonicamid;
  • M.10 Mite growth inhibitors for example M.10A clofentezine, hexythiazox and diflovidazin, or M.10B etoxazole;
  • M.1 1 Microbial disruptors of insect midgut membranes for example bacillus thuringiensis or bacillus sphaericus and the insecticdal proteins they produce such as bacillus thuringiensis subsp. israelensis, bacillus sphaericus, bacillus thuringiensis subsp. aizawai, bacillus
  • CrylAb CrylAc
  • Cryl Fa Cry2Ab
  • mCry3A Cry3Ab
  • Cry3Bb Cry34/35Ab1 ;
  • M.12 Inhibitors of mitochondrial ATP synthase for example M.12A diafenthiuron, or M.12B organotin miticides such as azocyclotin, cyhexatin or fenbutatin oxide, or M.12C propargite, or M.12D tetrad ifon;
  • Nicotinic acetylcholine receptor (nAChR) channel blockers for example nereistoxin analogues as bensultap, cartap hydrochloride, thiocyclam or thiosultap sodium;
  • benzoylureas as for example bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron or triflumuron;
  • M.16 Inhibitors of the chitin biosynthesis type 1 as for example buprofezin;
  • Ecdyson receptor agonists such as diacylhydrazines, for example methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide;
  • Octopamin receptor agonists as for example amitraz
  • M.20 Mitochondrial complex III electron transport inhibitors, for example M.20A
  • M.21 Mitochondrial complex I electron transport inhibitors for example M.21 A METI acaricides and insecticides such as fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad or tolfenpyrad, or M.21 B rotenone;
  • M.22 Voltage-dependent sodium channel blockers for example M.22A indoxacarb, or M.22B metaflumizone, or M.22B.1 : 2-[2-(4-Cyanophenyl)-1 -[3-(trifluoromethyl)phenyl]ethylidene]-N-[4- (difluoromethoxy)phenyl]-hydrazinecarboxamide or M.22B.2: N-(3-Chloro-2-methylphenyl)-2-[(4- chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide;
  • M.23 Inhibitors of the of acetyl CoA carboxylase such as Tetronic and Tetramic acid derivatives, for example spirodiclofen, spiromesifen or spirotetramat;
  • M.24 Mitochondrial complex IV electron transport inhibitors for example M.24A phosphine such as aluminium phosphide, calcium phosphide, phosphine or zinc phosphide, or M.24B cyanide; M.25 Mitochondrial complex II electron transport inhibitors, such as beta-ketonitrile derivatives, for example cyenopyrafen or cyflumetofen;
  • insecticidal active compounds of unknown or uncertain mode of action as for example afidopyropen, afoxolaner, azadirachtin, amidoflumet, benzoximate, bifenazate, broflanilide, bromopropylate, chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim, flometoquin, fluensulfone, fluhexafon, fluopyram, flupyradifurone, fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide, pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, triflumezopyrim, or the compounds
  • M.29.5 1 -[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1 H-1 ,2,4- triazole-5-amine, or actives on basis of bacillus firmus (Votivo, 1-1582); or
  • M.29.6a (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2- trifluoro-acetamide
  • M.29.6b (E/Z)-N-[1 -[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyndylidene]- 2,2,2-trifluoro-acetamide
  • M.29.6c (E/Z)-2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyndyl)methyl]-2- pyridylidene]acetamide
  • M.29.6d (E/Z)-N-[1 -[(6-bromo-3-pyridyl)methyl]-2
  • M.29.9.a 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 - oxothietan-3-yl)benzamide; or M.29.9.b): fluxametamide; or
  • M.29.10 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1 H-pyrazole; or a compound selected from the group of M.29.1 1 , wherein the compound is selected from M.29.1 1 b) to M.29.1 1 p): M.29.1 1 .b) 3-(benzoylmethylamino)-N-[2-bromo-4-[1 , 2,2,3,3,3- hexafluoro-1 -(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; M.29.1 1.c)
  • M.29.14a 1 -[(6-Chloro-3-pyridinyl)methyl]-1 , 2,3,5, 6,7-hexahydro-5-methoxy-7-methyl-8-nitro- imidazo[1 ,2-a]pyridine; or M.29.14b) 1 -[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro- 1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridin-5-ol; or the compounds
  • M.29.16a 1 -isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or M.29.16b) 1 - (1 ,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.29.16c) N,5- dimethyl-N-pyridazin-4-yl-1 -(2,2,2-trifluoro-1 -methyl-ethyl)pyrazole-4-carboxamide; M.29.16d) 1 - [1 -(1 -cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;
  • M.29.16e N-ethyl-1 -(2-fluoro-1 -methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4- carboxamide
  • M.29.16f 1 -(1 ,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4- carboxamide
  • M.29.16h N-methyl-1 -(2-fluoro-1 -methyl-propyl]-5-methyl-N-pyridazin-4-yl- pyrazole-4-carboxamide
  • M.29.16i 1 -(4,4-difluorocyclohexyl)-N-ethyl-5
  • M.29.17 a compound selected from the compounds M.29.17a) to M.29.17j): M.29.17a) N-(1 - methylethyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide; M.29.17b) N-cyclopropyl-2-(3- pyridinyl)-2H-indazole-4-carboxamide; M.29.17c) N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4- carboxamide; M.29.17d) 2-(3-pyridinyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide; M.29.17e) 2-(3-pyridinyl)-N-[(tetrahydro-2-furanyl)methyl]-2H-indazole-5-carboxamide;
  • M.29.17f methyl 2-[[2-(3-pyridinyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate; M.29.17g) N- [(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide; M.29.17h) N-(2,2- difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5-carboxamide; M.29.17i) 2-(3-pyridinyl )-N-(2- pyrimidinylmethyl )-2H-indazole-5-carboxamide; M.29.17j) N-[(5-methyl-2-pyrazinyl)methyl]-2- (3-pyridinyl)-2H-indazole-5-carboxamide, or
  • M.29.18 a compound selected from the compounds M.29.18a) to M.29.18d): M.29.18a) N-[3- chloro-1 -(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfanyl)propanamide; M.29.18b) N-[3-chloro-1 -(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)propanamide;
  • M.29.18c N-[3-chloro-1 -(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfanyl]-N- ethyl-propanamide; M.29.18d) N-[3-chloro-1 -(3-pyridyl)pyrazol-4-yl]-3-[(2,2- difluorocyclopropyl)methylsulfinyl]-N-ethyl-propanamide; or the compound
  • the M.4 neonicotinoid cycloxaprid is known from WO2010/069266 and WO201 1/069456, the neonicotinoid M.4A.2, sometimes also to be named as guadipyr, is known from
  • WO2013/003977 and the neonicotinoid M.4A.3 (approved as paichongding in China) is known from WO2007/101369.
  • the metaflumizone analogue M.22B.1 is described in CN10171577 and the analogue M.22B.2 in CN102126994.
  • the phthalamides M.28.1 and M.28.2 are both known from WO2007/101540.
  • the anthranilamide M.28.3 is described in WO2005/077934.
  • the hydrazide compound M.28.4 is described in WO2007/043677.
  • the anthranilamides M.28.5a) to M.28.5d) and M.28.5h) are described in WO 2007/006670, WO2013/024009 and
  • WO2013/024010 the anthranilamide ⁇ .28.5 ⁇ ) is described in WO201 1/085575, M.28.5j) in WO2008/134969, M.28.5k) in US201 1/046186 and M.28.5I) in WO2012/034403.
  • the diamide compound M.28.6 can be found in WO2012/034472.
  • the spiroketal-substituted cyclic ketoenol derivative M.29.3 is known from WO2006/089633 and the biphenyl-substituted spirocyclic ketoenol derivative M.29.4 from WO2008/06791 1 .
  • the triazoylphenylsulfide M.29.5 is described in WO2006/043635, and biological control agents on the basis of bacillus firmus are described in WO2009/124707.
  • the compounds M.29.6a) to ⁇ .29.6 ⁇ ) listed under M.29.6 are described in WO2012/029672, and M.29.6j) and M.29.6k) in WO2013/129688.
  • the nematicide M.29.8 is known from WO2013/055584.
  • the isoxazoline M.29.9.a) is described in WO2013/050317.
  • the isoxazoline M.29.9.b) is described in WO2014/126208.
  • the pyridalyl-type analogue M.29.10 is known from WO2010/060379.
  • the carboxamides broflanilide and M.29.1 1.b) to M.29.1 1 .h) are described in WO2010/018714, and the carboxamides M.29.1 1 i) to M.29.1 1.p) in
  • WO2010/006713, M.29.12.d) and M.29.12.e) are known from WO2012/000896, and M.29.12. ⁇ ) to M.29.12.m) from WO2010/129497.
  • the compounds M.29.14a) and M.29.14b) are known from WO2007/101369.
  • the pyrazoles M.29.16.a) to M.29.16h) are described in
  • WO2010/034737, WO2012/084670, and WO2012/143317, respectively, and the pyrazoles ⁇ .29.16 ⁇ ) and M.29.16j) are described in US 61/891437.
  • the pyridinylindazoles M.29.17a) to M.29.17J) are described in WO2015/038503.
  • the pyridylpyrazoles M.29.18a) to M.29.18d) are described in US2014/0213448.
  • the isoxazoline M.29.19 is described in WO2014/036056.
  • the isoxazoline M.29.20 is known from WO2014/090918.
  • Inhibitors of complex III at Q 0 site e. g. strobilurins: azoxystrobin (A.1 .1 ), coumethoxy- strobin (A.1.2), coumoxystrobin (A.1 .3), dimoxystrobin (A.1.4), enestroburin (A.1 .5),
  • fenaminstrobin (A.1 .6), fenoxystrobin/flufenoxystrobin (A.1 .7), fluoxastrobin (A.1 .8), kresoxim- methyl (A.1 .9), mandestrobin (A.1.10), metominostrobin (A.1.1 1 ), orysastrobin (A.1.12), picoxy- .strobin (A.1 .13), pyraclostrobin (A.1.14), pyrametostrobin (A.1 .15), pyraoxystrobin (A.1.16), trifloxystrobin (A.1.17), 2-(2-(3-(2,6-dichlorophenyl)-1 -methyl-allylideneaminooxymethyl)- phenyl)-2-methoxyimino-N-methyl-acetamide (A.1.18), pyribencarb (A.1.19),
  • triclopyricarb/chlorodincarb A.1.20
  • famoxadone A.1.21
  • fenamidone A.1 .21
  • methyl-A/-[2- [(1 ,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate A.1 .22
  • respiration inhibitors e. g. complex I, uncouplers: diflumetorim (A.4.1 ), (5,8- difluoroquinazolin-4-yl)- ⁇ 2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl ⁇ -amine (A.4.2); nitrophenyl derivates: binapacryl (A.4.3), dinobuton (A.4.4), dinocap (A.4.5), fluazinam (A.4.6); ferimzone (A.4.7); organometal compounds: fentin salts, such as fentin-acetate (A.4.8), fentin chloride (A.4.9) or fentin hydroxide (A.4.10); ametoctradin (A.4.1 1 ); and silthiofam
  • C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole (B.1.1 ), bitertanol (B.1.2), bromuconazole (B.1.3), cyproconazole (B.1 .4), difenoconazole (B.1 .5), diniconazole (B.1 .6), diniconazole-M (B.1 .7), epoxiconazole (B.1.8), fenbuconazole (B.1 .9), fluquinconazole (B.1.10), flusilazole (B.1 .1 1 ), flutriafol (B.1 .12), hexaconazole (B.1.13), imibenconazole (B.1.14), ipconazole (B.1.15), metconazole (B.1 .17), myclobutanil (B.1 .18), oxpoconazole (B.
  • Delta14-reductase inhibitors aldimorph (B.2.1 ), dodemorph (B.2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (B.2.6), piperalin (B.2.7), spiroxamine (B.2.8);
  • Inhibitors of 3-keto reductase fenhexamid (B.3.1 );
  • benalaxyl (C.1.1 ), benalaxyl-M (C.1 .2), kiralaxyl (C.1.3), metalaxyl (C.1.4), metalaxyl-M (mefenoxam, C.1 .5), ofurace (C.1.6), oxadixyl (C.1.7);
  • hymexazole C.2.1
  • octhilinone C.2.2
  • oxolinic acid C.2.3
  • bupirimate C.2.4
  • 5-fluorocytosine C.2.5
  • 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine C.2.6
  • 5-fluoro-2-(4- fluorophenylmethoxy)pyrimidin-4-amine C.2.7
  • tubulin inhibitors such as benzimidazoles, thiophanates: benomyl (D1 .1 ), carbendazim (D1 .2), fuberidazole (D1.3), thiabendazole (D1 .4), thiophanate-methyl (D1.5);
  • triazolopyrimidines 5-chloro-7-(4-methylpiperidin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]tri- azolo[1 ,5-a]pyrimidine (D1 .6);
  • diethofencarb (D2.1 ), ethaboxam (D2.2), pencycuron (D2.3), fluopicolide (D2.4), zoxamide (D2.5), metrafenone (D2.6), pyriofenone (D2.7);
  • methionine synthesis inhibitors anilino-pyrimidines: cyprodinil (E.1 .1 ), mepanipyrim (E.1.2), pyrimethanil (E.1 .3);
  • blasticidin-S (E.2.1 ), kasugamycin (E.2.2), kasugamycin hydrochloride-hydrate (E.2.3), mildiomycin (E.2.4), streptomycin (E.2.5), oxytetracyclin (E.2.6), polyoxine (E.2.7), validamycin A (E.2.8);
  • fluoroimid F.1 .1
  • iprodione F.1 .2
  • procymidone F.1 .3
  • vinclozolin F.1.4
  • fenpiclonil F.1 .5
  • fludioxonil F.1.6
  • G protein inhibitors quinoxyfen (F.2.1 );
  • Phospholipid biosynthesis inhibitors edifenphos (G.1.1 ), iprobenfos (G.1 .2), pyrazophos (G.1.3), isoprothiolane (G.1 .4);
  • lipid peroxidation dicloran (G.2.1 ), quintozene (G.2.2), tecnazene (G.2.3), tolclofos- methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7);
  • phospholipid biosynthesis and cell wall deposition dimethomorph (G.3.1 ), flumorph (G.3.2), mandipropamid (G.3.3), pyrimorph (G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate (G.3.7) and N-(1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4- fluorophenyl) ester (G.3.8);
  • thio- and dithiocarbamates ferbam (H.2.1 ), mancozeb (H.2.2), maneb (H.2.3), metam (H.2.4), metiram (H.2.5), propineb (H.2.6), thiram (H.2.7), zineb (H.2.8), ziram (H.2.9);
  • organochlorine compounds e. g. phthalimides, sulfamides, chloronitriles: anilazine (H.3.1 ), chlorothalonil (H.3.2), captafol (H.3.3), captan (H.3.4), folpet (H.3.5), dichlofluanid (H.3.6), dichlorophen (H.3.7), hexachlorobenzene (H.3.8), pentachlorphenole (H.3.9) and its salts, phthalide (H.3.10), tolylfluanid (H.3.1 1 ), N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl- benzenesulfonamide (H.3.12);
  • guanidine H.4.1
  • dodine H.4.2
  • dodine free base H.4.3
  • guazatine H.4.4
  • guazatine-acetate H.4.5
  • iminoctadine H.4.6
  • iminoctadine-triacetate H.4.7
  • iminoctadine-tris(albesilate) H.4.8
  • dithianon H.4.9
  • 2,6-dimethyl-1 H,5H- [1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone H.4.10
  • melanin synthesis inhibitors pyroquilon (1.2.1 ), tricyclazole (I.2.2), carpropamid (1.2.3), dicyclomet (1.2.4), fenoxanil (1.2.5);
  • acibenzolar-S-methyl J.1.1
  • probenazole J.1 .2
  • isotianil J.1 .3
  • tiadinil J.1.4
  • prohexadione-calcium J.1.5
  • phosphonates fosetyl (J.1 .6), fosetyl-aluminum (J.1 .7), phosphorous acid and its salts (J.1 .8), potassium or sodium bicarbonate (J.1 .9);
  • bronopol K.1.1
  • chinomethionat K.1 .2
  • cyflufenamid K.1.3
  • cymoxanil K.1 .4
  • dazomet K.1 .5
  • debacarb K.1.6
  • diclomezine K.1 .7
  • difenzoquat K.1 .8
  • difenzoquat- methylsulfate K.1.9
  • diphenylamin K.1 .10
  • fenpyrazamine K.1 .1 1
  • flumetover K.1.12
  • flusulfamide K.1 .13
  • flutianil K.1 .14
  • methasulfocarb K.1 .15
  • nitrapyrin K.1 .16
  • nitrothal- isopropyl K.1.18
  • oxathiapiprolin K.1 .19
  • tolprocarb K.1.20
  • fungicides described by common names, their preparation and their activity e.g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available.
  • fungicides described by lUPAC nomenclature, their preparation and their pesticidal activity is also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031 ; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941 ; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197;
  • the invention also relates to agrochemical compositions comprising an auxiliary and at least one compound of the present invention or a mixture thereof.
  • An agrochemical composition comprises a pesticidally effective amount of a compound of the present invention or a mixture thereof.
  • the term "pesticidally effective amount” is defined below.
  • the compounds of the present invention or the mixtures thereof can be converted into customary types of agro-chemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof.
  • agro-chemical compositions e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof.
  • composition types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF).
  • suspensions e.g. SC, OD, FS
  • emulsifiable concentrates e.g. EC
  • emulsions e.g. EW, EO, ES, ME
  • capsules e.g. CS, ZC
  • compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical Mono-graph No. 2, 6th Ed. May 2008, CropLife International.
  • the compositions are prepared in a known manner, such as described by Mollet and Grube- mann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.
  • auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfac- tants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifi- ers and binders.
  • suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfac- tants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifi- ers and binders.
  • Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil frac- tions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclo ⁇ hexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g.
  • mineral oil frac- tions of medium to high boiling point e.g. kerosene, diesel oil
  • oils of vegetable or animal origin oils of vegetable or animal origin
  • aliphatic, cyclic and aromatic hydrocarbons e. g. toluene, paraffin, tetrahydronaphthal
  • lactates carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.
  • Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharide powders, e.g. cellulose, starch;
  • fertilizers e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas
  • products of vegetable origin e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
  • Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emusifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
  • Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof.
  • sulfonates are alkylaryl- sulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkyhnaphthalenes, sulfosuccinates or sulfosuccinamates.
  • Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethox- ylated alcohols, or of fatty acid esters.
  • Examples of phosphates are phosphate esters.
  • Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol eth- oxylates.
  • Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof.
  • alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents.
  • Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide.
  • Exam- pies of N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides.
  • esters are fatty acid esters, glycerol esters or monoglycerides.
  • sugar- based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides.
  • polymeric surfactants are homo- or copolymers of
  • Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines.
  • Suitable amphoteric surfactants are alkylbetains and imidazolines.
  • Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide.
  • Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.
  • Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compounds of the present invention on the target.
  • examples are surfactants, mineral or vegetable oils, and other auxilaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
  • Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), anorganic clays (organically modified or unmodified), polycarboxylates, and silicates.
  • Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazoli- nones and benzisothiazolinones.
  • Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
  • Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
  • Suitable colorants are pigments of low water solubility and water- soluble dyes.
  • examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanofer- rate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).
  • Suitable tackifiers or binders are polyvinylpyrrolidone, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.
  • composition types and their preparation are:
  • alcohol alkoxylates are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) up to 100 wt%.
  • a water-soluble solvent e.g. alcohols
  • the active substance dissolves upon dilution with water.
  • a compound I according to the invention 5-25 wt% of a compound I according to the invention and 1 -10 wt% dispersant (e. g. polyvinylpyrrolidone) are dissolved in up to 100 wt% organic solvent (e.g. cyclohexanone). Dilution with water gives a dispersion,
  • emulsifiers e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate
  • 20-40 wt% water-insoluble organic solvent e.g. aromatic hydrocarbon
  • a compound I according to the invention 20-60 wt% of a compound I according to the invention are comminuted with addition of 2-10 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0,1 -2 wt% thickener (e.g. xanthan gum) and up to 100 wt% water to give a fine active substance suspension. Dilution with water gives a stable suspension of the active sub-stance. For FS type composition up to 40 wt% binder (e.g. polyvinylalcohol) is added.
  • dispersants and wetting agents e.g. sodium lignosulfonate and alcohol ethoxylate
  • 0,1 -2 wt% thickener e.g. xanthan gum
  • 50-80 wt% of a compound I according to the invention are ground finely with addition of up to 100 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.
  • dispersants and wetting agents e.g. sodium lignosulfonate and alcohol ethoxylate
  • wt% of a compound I according to the invention are ground in a rotor-stator mill with addition of 1 -5 wt% dispersants (e.g. sodium lignosulfonate), 1 -3 wt% wetting agents (e.g. alcohol ethoxylate) and up to 100 wt% solid carrier, e.g. silica gel. Dilution with water gives a stable dispersion or solution of the active substance.
  • dispersants e.g. sodium lignosulfonate
  • 1 -3 wt% wetting agents e.g. alcohol ethoxylate
  • solid carrier e.g. silica gel
  • a compound I according to the invention In an agitated ball mill, 5-25 wt% of a compound I according to the invention are comminuted with addition of 3-10 wt% dispersants (e.g. sodium lignosulfonate), 1 -5 wt% thickener (e.g. car- boxymethylcellulose) and up to 100 wt% water to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.
  • dispersants e.g. sodium lignosulfonate
  • 1 -5 wt% thickener e.g. car- boxymethylcellulose
  • 5-20 wt% of a compound I according to the invention are added to 5-30 wt% organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 wt% surfactant blend (e.g. alkohol ethoxylate and arylphenol ethoxylate), and water up to 100 %. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.
  • organic solvent blend e.g. fatty acid dimethylamide and cyclohexanone
  • surfactant blend e.g. alkohol ethoxylate and arylphenol ethoxylate
  • An oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e.g.
  • methylmethacrylate, methacrylic acid and a di- or triacrylate are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules.
  • a protective colloid e.g. polyvinyl alcohol
  • an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylme- thene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol).
  • a polyamine e.g. hexamethylenediamine
  • the monomers amount to 1 -10 wt%.
  • Dustable powders (DP, DS)
  • 1 -10 wt% of a compound I according to the invention are ground finely and mixed intimately with up to 100 wt% solid carrier, e.g. finely divided kaolin.
  • 0.5-30 wt% of a compound I according to the invention is ground finely and associated with up to 100 wt% solid carrier (e.g. silicate). Granulation is achieved by extrusion, spray-drying or the fluidized bed.
  • solid carrier e.g. silicate
  • a compound I according to the invention are dissolved in up to 100 wt% organic solvent, e.g. aromatic hydrocarbon.
  • organic solvent e.g. aromatic hydrocarbon.
  • compositions types i) to xi) may optionally comprise further auxiliaries, such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
  • auxiliaries such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
  • the agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and most preferably between 0.5 and 75%, by weight of active sub-stance.
  • the active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
  • oils, wetters, adjuvants, fertilizer, or micronutrients, and other pesticides may be added to the active substances or the compositions cormprising them as premix or, if appropriate not until immediately prior to use (tank mix).
  • pesticides e.g. herbicides, insecticides, fungicides, growth regulators, safeners
  • These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.
  • the user applies the composition according to the invention usually from a predosage de-vice, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system.
  • the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained.
  • 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.
  • composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.
  • either individual components of the composition according to the invention or partially premixed components may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate.
  • either individual components of the composition according to the in- vention or partially premixed components can be applied jointly (e.g. after tank mix) or consecutively.
  • the compounds of the present invention are suitable for use in protecting crops, plants, plant propagation materials, such as seeds, or soil or water, in which the plants are growing, from attack or infestation by animal pests. Therefore, the present invention also relates to a plant protection method, which comprises contacting crops, plants, plant propagation materials, such as seeds, or soil or water, in which the plants are growing, to be protected from attack or infestation by animal pests, with a pesticidally effective amount of a compound of the present invention.
  • the compounds of the present invention are also suitable for use in combating or controlling animal pests. Therefore, the present invention also relates to a method of combating or controlling animal pests, which comprises contacting the animal pests, their habitat, breeding ground, or food supply, or the crops, plants, plant propagation materials, such as seeds, or soil, or the area, material or environment in which the animal pests are growing or may grow, with a pesticidally effective amount of a compound of the present invention.
  • the compounds of the present invention are effective through both contact and ingestion. Furthermore, the compounds of the present invention can be applied to any and all
  • the compounds of the present invention can be applied as such or in form of compositions comprising them as defined above. Furthermore, the compounds of the present invention can be applied together with a mixing partner as defined above or in form of compositions comprising said mixtures as defined above.
  • the components of said mixture can be applied simultaneously, jointly or separately, or in succession, that is immediately one after another and thereby creating the mixture "in situ" on the desired location, e.g. the plant, the sequence, in the case of separate application, generally not having any effect on the result of the control measures.
  • the application can be carried out both before and after the infestation of the crops, plants, plant propagation materials, such as seeds, soil, or the area, material or environment by the pests.
  • Suitable application methods include inter alia soil treatment, seed treatment, in furrow application, and foliar application.
  • Soil treatment methods include drenching the soil, drip irrigation (drip application onto the soil), dipping roots, tubers or bulbs, or soil injection.
  • Seed treatment techniques include seed dressing, seed coating, seed dusting, seed soaking, and seed pelleting.
  • furrow applications typically include the steps of making a furrow in cultivated land, seeding the furrow with seeds, applying the pesticidally active compound to the furrow, and closing the furrow.
  • Foliar application refers to the application of the pesticidally active compound to plant foliage, e.g. through spray equipment.
  • pheromones for specific crops and pests are known to a skilled person and publicly available from databases of pheromones and
  • contacting includes both direct contact (applying the
  • animal pest includes arthropods, gastropods, and nematodes.
  • Preferred animal pests according to the invention are arthropods, preferably insects and arachnids, in particular insects.
  • Insects, which are of particular relevance for crops, are typically referred to as crop insect pests.
  • crop refers to both, growing and harvested crops.
  • plant includes cereals, e.g. durum and other wheat, rye, barley, triticale, oats, rice, or maize (fodder maize and sugar maize / sweet and field corn); beet, e.g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e.g.
  • iceberg lettuce chicory, cabbage, asparagus, cabbages, carrots, onions, garlic, leeks, tomatoes, potatoes, cucurbits or sweet peppers; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rapeseed, sugar cane or oil palm; tobacco; nuts, e.g. walnuts; pistachios; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers (e.g. carnation, petunias,
  • geranium/pelargoniums pansies and impatiens
  • shrubs broad-leaved trees (e.g. poplar) or evergreens, e.g. conifers; eucalyptus; turf; lawn; grass such as grass for animal feed or ornamental uses.
  • Preferred plants include potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rapeseed, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
  • plant is to be understood as including wild type plants and plants, which have been modified by either conventional breeding, or mutagenesis or genetic engineering, or by a combination thereof.
  • Plants which have been modified by mutagenesis or genetic engineering, and are of particular commercial importance, include alfalfa, rapeseed (e.g. oilseed rape), bean, carnation, chicory, cotton, eggplant, eucalyptus, flax, lentil, maize, melon, papaya, petunia, plum, poplar, potato, rice, soybean, squash, sugar beet, sugarcane, sunflower, sweet pepper, tobacco, tomato, and cereals (e.g. wheat), in particular maize, soybean, cotton, wheat, and rice.
  • rapeseed e.g. oilseed rape
  • the one or more mutagenized or integrated genes are preferably selected from pat, epsps, cry1 Ab, bar, cry1 Fa2, cry1 Ac, cry34Ab1 , cry35AB1 , cry3A, cryF, cry1 F, mcry3a, cry2Ab2, cry3Bb1 , cry1A.105, dfr, barnase, vip3Aa20, barstar, als, bxn, bp40, asnl , and ppo5.
  • the mutagenesis or integration of the one or more genes is performed in order to improve certain properties of the plant.
  • Such properties include abiotic stress tolerance, altered growth/yield, disease resistance, herbicide tolerance, insect resistance, modified product quality, and pollination control.
  • herbicide tolerance e.g. imidazolinone tolerance, glyphosate tolerance, or glufosinate tolerance
  • mutagenesis Several plants have been rendered tolerant to herbicides by mutagenesis, for example Clearfield® oilseed rape being tolerant to
  • imidazolinones e.g. imazamox.
  • genetic engineering methods have been used to render plants, such as soybean, cotton, corn, beets and oil seed rape, tolerant to herbicides, such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate) and LibertyLink® (glufosinate).
  • herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate) and LibertyLink® (glufosinate).
  • glyphosate and glufosinate some of which are commercially available under the trade names RoundupReady® (glyphosate) and LibertyLink® (glufosinate).
  • insect resistance is of importance, in particular lepidopteran insect resistance and coleopteran insect resistance.
  • Insect resistance is typically achieved by modifying plants by integrating cry and/or vip genes, which were
  • Plants may be modified by mutagenesis or genetic engineering either in terms of one property (singular traits) or in terms of a combination of properties (stacked traits). Stacked traits, e.g. the combination of herbicide tolerance and insect resistance, are of increasing importance.
  • the pesticidal activity of the compounds of the present invention may be enhanced by the insecticidal trait of a modified plant. Furthermore, it has been found that the compounds of the present invention are suitable for preventing insects to become resistant to the insecticidal trait or for combating pests, which already have become resistant to the insecticidal trait of a modified plant. Moreover, the compounds of the present invention are suitable for combating pests, against which the insecticidal trait is not effective, so that a complementary insecticidal activity can advantageously be used.
  • plant propagation material refers to all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e.g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants. Seedlings and young plants, which are to be transplanted after germination or after emergence from soil, may also be included. These plant propagation materials may be treated prophylactically with a plant protection compound either at or before planting or transplanting.
  • seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corms, bulbs, fruit, tubers, grains, cuttings, cut shoots and the like, and means in a preferred embodiment true seeds.
  • pesticidally effective amount means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism.
  • the pesticidally effective amount can vary for the various compounds/compositions used in the invention.
  • a pesticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like.
  • the quantity of active ingredient ranges from 0.0001 to 500 g per 100 m 2 , preferably from 0.001 to 20 g per 100 m 2 .
  • the rate of application of the active ingredients of this invention may be in the range of 0.0001 g to 4000 g per hectare, e.g. from 1 g to 2 kg per hectare or from 1 g to 750 g per hectare, desirably from 1 g to 100 g per hectare, more desirably from 10 g to 50 g per hectare, e.g., 10 to 20 g per hectare, 20 to 30 g per hectare, 30 to 40 g per hectare, or 40 to 50 g per hectare.
  • the compounds of the present invention are particularly suitable for use in the treatment of seeds in order to protect the seeds from insect pests, in particular from soil-living insect pests, and the resulting seedling's roots and shoots against soil pests and foliar insects.
  • the present invention therefore also relates to a method for the protection of seeds from insects, in particular from soil insects, and of the seedling's roots and shoots from insects, in particular from soil and foliar insects, said method comprising treating the seeds before sowing and/or after
  • pregermination with a compound of the present invention pregermination with a compound of the present invention.
  • the protection of the seedling's roots and shoots is preferred. More preferred is the protection of seedling's shoots from piercing and sucking insects, chewing insects and nematodes.
  • seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking, seed pelleting, and in-furrow application methods.
  • seed treatment application of the active compound is carried out by spraying or by dusting the seeds before sowing of the plants and before emergence of the plants.
  • the present invention also comprises seeds coated with or containing the active compound.
  • coated with and/or containing generally signifies that the active ingredient is for the most part on the surface of the propagation product at the time of application, although a greater or lesser part of the ingredient may penetrate into the propagation product, depending on the method of application. When the said propagation product is (re)planted, it may absorb the active ingredient.
  • Suitable seed is for example seed of cereals, root crops, oil crops, vegetables, spices, ornamentals, for example seed of durum and other wheat, barley, oats, rye, maize (fodder maize and sugar maize / sweet and field corn), soybeans, oil crops, crucifers, cotton, sunflowers, bananas, rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants, potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks, pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons, Brassica species, melons, beans, peas, garlic, onions, carrots, tuberous plants such as potatoes, sugar cane, tobacco, grapes, petunias,
  • the active compound may also be used for the treatment of seeds from plants, which have been modified by mutagenisis or genetic engineering, and which e.g. tolerate the action of herbicides or fungicides or insecticides. Such modified plants have been described in detail above.
  • Conventional seed treatment formulations include for example flowable concentrates FS, solutions LS, suspoemulsions (SE), powders for dry treatment DS, water dispersible powders for slurry treatment WS, water-soluble powders SS and emulsion ES and EC and gel formulation GF. These formulations can be applied to the seed diluted or undiluted. Application to the seeds is carried out before sowing, either directly on the seeds or after having
  • the formulations are applied such that germination is not included.
  • the active substance concentrations in ready-to-use formulations are preferably from 0.01 to 60% by weight, more preferably from 0.1 to 40 % by weight.
  • a FS formulation is used for seed treatment.
  • a FS formulation may comprise 1 -800 g/l of active ingredient, 1 -200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water.
  • Especially preferred FS formulations of the compounds of the present invention for seed treatment usually comprise from 0.1 to 80% by weight (1 to 800 g/l) of the active ingredient, from 0.1 to 20 % by weight (1 to 200 g/l) of at least one surfactant, e.g. 0.05 to 5 % by weight of a wetter and from 0.5 to 15 % by weight of a dispersing agent, up to 20 % by weight, e.g. from 5 to 20 % of an anti-freeze agent, from 0 to 15 % by weight, e.g. 1 to 15 % by weight of a pigment and/or a dye, from 0 to 40 % by weight, e.g.
  • a binder (sticker /adhesion agent), optionally up to 5 % by weight, e.g. from 0.1 to 5 % by weight of a thickener, optionally from 0.1 to 2 % of an anti-foam agent, and optionally a preservative such as a biocide, antioxidant or the like, e.g. in an amount from 0.01 to 1 % by weight and a filler/vehicle up to 100 % by weight.
  • a binder sticker /adhesion agent
  • a preservative such as a biocide, antioxidant or the like
  • the application rates of the compounds of the invention are generally from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 5 kg per 100 kg of seed, more preferably from 1 g to 1000 g per 100 kg of seed and in particular from 1 g to 200 g per 100 kg of seed, e.g. from 1 g to 100 g or from 5 g to 100 g per 100 kg of seed.
  • the invention therefore also relates to seed comprising a compound of the present invention, or an agriculturally useful salt thereof, as defined herein.
  • the amount of the compound of the present invention or the agriculturally useful salt thereof will in general vary from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 5 kg per 100 kg of seed, in particular from 1 g to 1000 g per 100 kg of seed. For specific crops such as lettuce the rate can be higher.
  • the compounds of the present invention may also be used for improving the health of a plant. Therefore, the present invention also relates to a method for improving plant health by treating a plant, plant propagation material and/or the locus where the plant is growing or is to grow with an effective and non-phytotoxic amount of a compound of the present invention.
  • an effective and non-phytotoxic amount means that the compound is used in a quantity which allows to obtain the desired effect but which does not give rise to any phytotoxic symptom on the treated plant or on the plant grown from the treated propagule or treated soil.
  • plant and “plant propagation material” are defined above.
  • Plant health is defined as a condition of the plant and/or its products which is determined by several aspects alone or in combination with each other such as yield (for example increased biomass and/or increased content of valuable ingredients), quality (for example improved content or composition of certain ingredients or shelf life), plant vigour (for example improved plant growth and/or greener leaves ("greening effect"), tolerance to abiotic (for example drought) and/or biotic stress (for example disease) and production efficiency (for example, harvesting efficiency, processability).
  • yield for example increased biomass and/or increased content of valuable ingredients
  • quality for example improved content or composition of certain ingredients or shelf life
  • plant vigour for example improved plant growth and/or greener leaves ("greening effect")
  • tolerance to abiotic for example drought
  • biotic stress for example disease
  • production efficiency for example, harvesting efficiency, processability
  • the above identified indicators for the health condition of a plant may be interdependent and may result from each other.
  • Each indicator is defined in the art and can be determined by methods known to a skilled person.
  • the compounds of the invention are also suitable for use against non-crop insect pests.
  • compounds of the present invention can be used as bait composition, gel, general insect spray, aerosol, as ultra-low volume application and bed net (impregnated or surface applied).
  • drenching and rodding methods can be used.
  • non-crop insect pest refers to pests, which are particularly relevant for non-crop targets, such as ants, termites, wasps, flies, ticks, mosquitos, crickets, or cockroaches.
  • the bait can be a liquid, a solid or a semisolid preparation (e.g. a gel).
  • the bait employed in the composition is a product, which is sufficiently attractive to incite insects such as ants, termites, wasps, flies, mosquitos, crickets etc. or cockroaches to eat it.
  • the attractiveness can be manipulated by using feeding stimulants or sex pheromones.
  • Food stimulants are chosen, for example, but not exclusively, from animal and/or plant proteins (meat-, fish- or blood meal, insect parts, egg yolk), from fats and oils of animal and/or plant origin, or mono-, oligo- or polyorganosaccharides, especially from sucrose, lactose, fructose, dextrose, glucose, starch, pectin or even molasses or honey. Fresh or decaying parts of fruits, crops, plants, animals, insects or specific parts thereof can also serve as a feeding stimulant. Sex pheromones are known to be more insect specific. Specific pheromones are described in the literature (e.g. http://www.pherobase.com), and are known to those skilled in the art.
  • the typical content of active ingredient is from 0.001 weight % to 15 weight %, desirably from 0.001 weight % to 5% weight % of active compound.
  • Formulations of the compounds of the present invention as aerosols are highly suitable for the non-professional user for controlling pests such as flies, fleas, ticks, mosquitos or cockroaches.
  • Aerosol recipes are preferably composed of the active compound, solvents, furthermore auxiliaries such as emulsifiers, perfume oils, if appropriate stabilizers, and, if required, propellants.
  • the oil spray formulations differ from the aerosol recipes in that no propellants are used.
  • the content of active ingredient is from 0.001 to 80 weights %, preferably from 0.01 to 50 weight % and most preferably from 0.01 to 15 weight %.
  • the compounds of the present invention and its respective compositions can also be used in mosquito and fumigating coils, smoke cartridges, vaporizer plates or long-term vaporizers and also in moth papers, moth pads or other heat-independent vaporizer systems.
  • Methods to control infectious diseases transmitted by insects e.g. malaria, dengue and yellow fever, lymphatic filariasis, and leishmaniasis
  • compounds of the present invention and its respective compositions also comprise treating surfaces of huts and houses, air spraying and impregnation of curtains, tents, clothing items, bed nets, tsetse-fly trap or the like.
  • Insecticidal compositions for application to fibers, fabric, knitgoods, nonwovens, netting material or foils and tarpaulins preferably comprise a mixture including the insecticide, optionally a repellent and at least one binder.
  • the compounds of the present invention and its compositions can be used for protecting wooden materials such as trees, board fences, sleepers, frames, artistic artifacts, etc. and buildings, but also construction materials, furniture, leathers, fibers, vinyl articles, electric wires and cables etc. from ants and/or termites, and for controlling ants and termites from doing harm to crops or human being (e.g. when the pests invade into houses and public facilities).
  • Customary application rates in the protection of materials are, for example, from 0.001 g to 2000 g or from 0.01 g to 1000 g of active compound per m 2 treated material, desirably from 0.1 g to 50 g per m 2 .
  • Insecticidal compositions for use in the impregnation of materials typically contain from 0.001 to 95 weight %, preferably from 0.1 to 45 weight %, and more preferably from 1 to 25 weight % of at least one repellent and/or insecticide.
  • the compounds of the present invention are especially suitable for efficiently combating animal pests such as arthropods, gastropods and nematodes including but not limited to:
  • insects from the order of Lepidoptera for example Achroia grisella, Acleris spp. such as A. fimbriana, A. gloverana, A. variana; Acrolepiopsis assectella, Acronicta major, Adoxophyes spp. such as A. cyrtosema, A. orana; Aedia leucomelas, Agrotis spp. such as A. exclamationis, A. fucosa, A. ipsilon, A. orthogoma, A. segetum, A.
  • Athetis mindara Austroasca viridigrisea, Autographa gamma, Autographa nigrisigna, Barathra brassicae, Bedellia spp., Bonagota salubricola, Borbo cinnara, Bucculatrix thurberiella, Bupalus piniarius, Busseola spp., Cacoecia spp. such as C. murinana, C. podana; Cactoblastis cactorum, Cadra cautella, Calingo braziliensis, Caloptilis theivora, Capua reticulana, Carposina spp. such as C. niponensis, C.
  • Cephus spp. Chaetocnema aridula, Cheimatobia brumata, Chilo spp. such as C. Indicus, C. suppressalis, C. partellus; Choreutis pariana, Choristoneura spp. such as C. conflictana, C. fumiferana, C. longicellana, C. murinana, C. occidentalis, C. rosaceana;
  • Dendrolimus spp. such as D. pini, D. spectabilis, D. sibiricus; Desmia funeralis, Diaphania spp. such as D. nitidalis, D. hyalinata; Diatraea grandiosella, Diatraea saccharalis, Diphthera festiva, Earias spp. such as E. insulana, E.
  • kuehniella kuehniella; Epinotia aporema, Epiphyas postvittana, Erannis tiliaria, Erionota thrax, Etiella spp., Eulia spp., Eupoecilia ambiguella, Euproctis chrysorrhoea, Euxoa spp., Evetria bouliana, Faronta albilinea, Feltia spp. such as F. subterranean; Galleria mellonella, Gracillaria spp., Grapholita spp. such as G.
  • H. armigera Heliothis armigera
  • H. zea Heliothis zea
  • Heliothis spp. such as H. assulta, H. subflexa, H. virescens
  • Hellula spp. such as H. undalis, H.
  • M. neustria M. neustria
  • Mamestra spp. such as M. brassicae, M. configurata
  • Mamstra brassicae Manduca spp.
  • M. quinquemaculata M. sexta
  • Mods spp. such as M. lapites, M.
  • operculella Phyllocnistis citrella, Phyllonorycter spp. such as P. blancardella, P. crataegella, P. issikii, P. ringoniella; Pieris spp. such as P. brassicae, P. rapae, P. napi; Pilocrocis tripunctata, Plathypena scabra, Platynota spp. such as P. flavedana, P.
  • Thaumetopoea pityocampa Thecla spp., Theresimima ampelophaga, Thyrinteina spp, Tildenia inconspicuella, Tinea spp. such as T. cloacella, T. pellionella; Tineola bisselliella, Tortrix spp. such as T. viridana; Trichophaga tapetzella, Trichoplusia spp. such as T. ni; Tuta
  • insects from the order of Coleoptera for example Acalymma vittatum, Acanthoscehdes obtectus, Adoretus spp., Agelastica alni, Agrilus spp. such as A. anxius, A. planipennis, A. sinuatus; Agriotes spp. such as A. fuscicollis, A. lineatus, A. obscurus; Alphitobius diaperinus, Amphimallus solstitialis, Anisandrus dispar, Anisoplia austriaca, Anobium punctatum, Anomala diverenta, Anomala rufocuprea, Anoplophora spp. such as A.
  • Anthonomus spp. such as A. eugenii, A. grandis, A. pomorum; Anthrenus spp., Aphthona euphoridae, Apion spp., Apogonia spp., Athous haemorrhoidalis, Atomaria spp. such as A. linearis; Attagenus spp., Aulacophora femoralis, Blastophagus piniperda, Blitophaga undata, Bruchidius obtectus, Bruchus spp. such as B. lentis, B. pisorum, B.
  • Curculio spp. Cylindrocopturus spp., Cyclocephala spp., Dactylispa balyi, Dectes texanus, Dermestes spp., Diabrotica spp. such as D. undecimpunctata, D. speciosa, D. longicornis, D. semipunctata, D. virgifera; Diaprepes abbreviates, Dichocrocis spp., Dicladispa armigera, Diloboderus abderus, Diocalandra frumenti (Diocalandra stigmaticollis), Enaphalodes rufulus, Epilachna spp. such as E. varivestis, E.
  • vigintioctomaculata Epitrix spp. such as E. hirtipennis, E. similaris; Eutheola humilis, Eutinobothrus brasiliensis, Faustinus cubae, Gibbium psylloides, Gnathocerus cornutus, Hellula undalis, Heteronychus arator, Hylamorpha elegans, Hylobius abietis, Hylotrupes bajulus, Hypera spp. such as H. brunneipennis, H.
  • hypomeces squamosus Hypothenemus spp., Ips typographus, Lachnosterna consanguinea, Lasioderma serricorne, Latheticus oryzae, Lathridius spp., Lema spp. such as L. bilineata, L. melanopus; Leptinotarsa spp. such as L. decemlineata; Leptispa pygmaea, Limonius californicus,
  • Lissorhoptrus oryzophilus Lixus spp., Luperodes spp., Lyctus spp. such as L. bruneus;
  • Liogenys fuscus Macrodactylus spp. such as M. subspinosus
  • Maladera matrida Megaplatypus mutates
  • Megascelis spp. Melanotus communis, Meligethes spp. such as M. aeneus
  • M. aeneus Liogenys fuscus, Macrodactylus spp. such as M. subspinosus
  • Maladera matrida Megaplatypus mutates
  • Megascelis spp. Melanotus communis
  • Meligethes spp. such as M. aeneus
  • Melolontha spp. such as M. hippocastani, M. melolontha; Metamasius hemipterus, Microtheca spp., Migdolus spp. such as M. fryanus, Monochamus spp. such as M.
  • chrysocephala P. nemorum, P. striolata, P. vittula; Phyllopertha horticola, Popillia japonica, Premnotrypes spp., Psacothea hilaris, Psylliodes chrysocephala, Prostephanus truncates, Psylliodes spp., Ptinus spp., Pulga saltona, Rhizopertha dominica, Rhynchophorus spp. such as R. billineatus, R. ferrugineus, R. palmarum, R. phoenicis, R.
  • Trogoderma spp. Tychius spp.
  • Xylotrechus spp. such as X. pyrrhoderus
  • Zabrus spp. such as Z. tenebrioides
  • insects from the order of Diptera for example Aedes spp. such as A. aegypti, A. albopictus, A. vexans; Anastrepha ludens, Anopheles spp. such as A. albimanus, A. crucians, A. freeborni, A. gambiae, A. leucosphyrus, A. maculipennis, A. minimus, A. quadrimaculatus, A. sinensis;
  • Aedes spp. such as A. aegypti, A. albopictus, A. vexans
  • Anastrepha ludens Anopheles spp.
  • A. albimanus such as A. crucians, A. freeborni, A. gambiae, A. leucosphyrus, A. maculipennis, A. minimus, A. quadrimaculatus, A. sinensis;
  • Muscina stabulans, Oestrus spp. such as O. ovis; Opomyza florum, Oscinella spp. such as O. frit; Orseolia oryzae, Pegomya hysocyami, Phlebotomus argentipes, Phorbia spp. such as P. antiqua, P. brassicae, P. coarctata; Phytomyza gymnostoma,
  • Prosimulium mixtum, Psila rosae, Psorophora columbiae, Psorophora discolor, Rhagoletis spp. such as R. cerasi, R. cingulate, R. indifferens, R. mendax, R. pomonella; Rivellia quadrifasciata, Sarcophaga spp. such as S. haemorrhoidalis; Simulium vittatum, Sitodiplosis mosellana, Stomoxys spp. such as S. calcitrans; Tabanus spp. such as T. atratus, T. bovinus, T. lineola, T. similis; Tannia spp., Thecodiplosis japonensis, Tipula oleracea, Tipula paludosa, and
  • insects from the order of Thysanoptera for example, Basothrips biformis, Dichromothrips corbetti, Dichromothrips ssp., Echinothrips americanus, Enneothrips flavens, Frankliniella spp. such as F. fusca, F. occidentalis, F. tritici; Heliothrips spp., Hercinothrips femoralis, Kakothrips spp., Microcephalothrips abdominalis, Neohydatothrips samayunkur, Pezothrips kellyanus, Rhipiphorothrips cruentatus, Scirtothrips spp. such as S. citri, S. dorsalis, S. perseae;
  • Stenchaetothrips spp Taeniothrips cardamom, Taeniothrips inconsequens, Thrips spp. such as T. imagines, T. hawaiiensis, T. oryzae, T. palmi, T. parvispinus, T. tabaci;
  • insects from the order of Hemiptera for example, Acizzia jamatonica, Acrosternum spp. such as A. hilare; Acyrthosipon spp. such as A. onobrychis, A. pisum; Adelges laricis, Adelges tsugae, Adelphocoris spp., such as A. rapidus, A.
  • Aspidiotus spp. Atanus spp., Aulacaspis yasumatsui, Aulacorthum solani, Bactericera cockerelli (Paratrioza cockerelli), Bemisia spp. such as B. argentifolii, B. tabaci (Aleurodes tabaci); Blissus spp. such as B. leucopterus; Brachycaudus spp. such as B. cardui, B. helichrysi, B. persicae, B. prunicola; Brachycolus spp., Brachycorynella asparagi, Brevicoryne brassicae, Cacopsylla spp. such as C. fulguralis, C. pyricola (Psylla piri); Calligypona marginata, Calocoris spp.,
  • Coccomytilus halli Coccus spp. such as C. hesperidum, C. pseudomagnoliarum
  • Corythucha arcuata Creontiades dilutus, Cryptomyzus ribis, Chrysomphalus aonidum, Cryptomyzus ribis, Ctenarytaina spatulata, Cyrtopeltis notatus, Dalbulus spp., Dasynus piperis, Dialeurodes spp. such as D. citrifolii;
  • Dalbulus maidis Dalbulus maidis, Diaphorina spp. such as D. citri; Diaspis spp. such as D. bromeliae; Dichelops furcatus, Diconocoris hewetti, Doralis spp., Dreyfusia nordmannianae, Dreyfusia piceae, Drosicha spp., Dysaphis spp. such as D. plantaginea, D. pyri, D. radicola; Dysaulacorthum pseudosolani, Dysdercus spp. such as D. cingulatus, D. intermedius; Dysmicoccus spp., Edessa spp., Geocoris spp., Empoasca spp. such as E. fabae, E. solana; Epidiaspis leperii,
  • Idiocerus spp. Idioscopus spp., Laodelphax striatellus, Lecanium spp., Lecanoideus floccissimus, Lepidosaphes spp. such as L. ulmi; Leptocorisa spp., Leptoglossus phyllopus, Lipaphis erysimi, Lygus spp. such as L.
  • Parthenolecanium spp. such as P. corni, P. persicae; Pemphigus spp. such as P. bursarius, P. populivenae; Peregrinus maidis, Perkinsiella saccharicida, Phenacoccus spp. such as P. aceris, P. gossypii; Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp. such as P. devastatrix, Piesma quadrata, Piezodorus spp. such as P. guildinii; Pinnaspis aspidistrae, Planococcus spp. such as P. citri, P. ficus; Prosapia bicincta, Protopulvinaria pyriformis, Psallus seriatus,
  • pseudobrassicas R. insertum, R. maidis, R. padi; Sagatodes spp., Sahlbergella singularis, Saissetia spp., Sappaphis mala, Sappaphis mail, Scaptocoris spp., Scaphoides titanus,
  • Schizaphis graminum, Schizoneura lanuginosa, Scotinophora spp., Selenaspidus articulatus, Sitobion avenae, Sogata spp., Sogatella furcifera, Solubea insularis, Spissistilus festinus ( Stictocephala festina), Stephanitis nashi, Stephanitis pyrioides, Stephanitis takeyai,
  • Trialeurodes spp. such as T. abutilonea, T. ricini, T. vaporariorum; Triatoma spp., Trioza spp., Typhlocyba spp., Unaspis spp. such as U. citri, U. yanonensis; and Viteus vitifolii,
  • Iridomyrmex humilis Lasius spp. such as L. niger, Linepithema humile, Liometopum spp., Leptocybe invasa, Monomorium spp. such as M. pharaonis, Monomorium, Nylandria fulva, Pachycondyla chinensis, Paratrechina longicornis, Paravespula spp., such as P. germanica, P. pennsylvanica, P. vulgaris; Pheidole spp. such as P. megacephala; Pogonomyrmex spp. such as P. barbatus, P.
  • Vespula spp. such as V. squamosal
  • Wasmannia auropunctata Xylocopa sp
  • Insects from the order Orthoptera for example Acheta domesticus, Calliptamus italicus, Chortoicetes terminifera, Ceuthophilus spp., Diastrammena asynamora, Dociostaurus maroccanus, Gryllotalpa spp. such as G. africana, G. gryllotalpa; Gryllus spp., Hieroglyphus daganensis, Kraussaria angulifera, Locusta spp. such as L. migratoria, L. pardalina; Melanoplus spp. such as M. bivittatus, M. femurrubrum, M. mexicanus, M. sanguinipes, M. spretus;
  • Pests from the Class Arachnida for example Acari, e.g. of the families Argasidae, Ixodidae and Sarcoptidae, such as Amblyomma spp. (e.g. A. americanum, A. variegatum, A. maculatum), Argas spp. such as A. persicu), Boophilus spp. such as B. annulatus, B. decoloratus, B.
  • Amblyomma spp. e.g. A. americanum, A. variegatum, A. maculatum
  • Argas spp. such as A. persicu
  • Boophilus spp. such as B. annulatus, B. decoloratus, B.
  • Dermacentor spp. such as D.silvarum, D. andersoni, D. variabilis, Hyalomma spp. such as H. truncatum, Ixodes spp. such as /. ricinus, I. rubicundus, I. scapularis, I. holocyclus, I. pacificus, Rhipicephalus sanguineus, Omithodorus spp. such as O. moubata, O. hermsi, O. turicata, Omithonyssus bacoti, Otobius megnini, Dermanyssus gallinae, Psoroptes spp. such as P.
  • Rhipicephalus spp. such as R. sanguineus, R. appendiculatus, Rhipicephalus evertsi, Rhizoglyphus spp., Sarcoptes spp. such asS. Scabiei; and Family Eriophyidae including Aceria spp. such as A. sheldoni, A. anthocoptes, Acallitus spp., Aculops spp. such as A. lycopersici, A. pelekassi; Aculus spp. such as A. pointedendali; Colomerus vitis, Epitrimerus pyri,
  • Tenuipalpidae including Brevipalpus spp. such as B. phoenicis; Family Tetranychidae including Eotetranychus spp., Eutetranychus spp., Oligonychus spp., Petrobia latens, Tetranychus spp. such as T. cinnabarinus, T. evansi, T. kanzawai, T, pacificus, T. phaseulus, T. telarius and T. urticae; Bryobia praetiosa; Panonychus spp. such as P. ulmi, P. citri; Metatetranychus spp. and Oligonychus spp.
  • Family Tetranychidae including Eotetranychus spp., Eutetranychus spp., Oligonychus spp., Petrobia latens, Tetranychus spp. such as T. cinna
  • Trombicula spp. Family Cellyssidae including Ornothonyssus spp.; Family Pyemotidae including Pyemotes tritici; Tyrophagus putrescentiae; Family Acaridae including Acarus siro; Family Araneida including Latrodectus mactans, Tegenaria agrestis, Chiracanthium sp, Lycosa sp Achaearanea tepidariorum and Loxosceles reclusa;
  • Pests from the Phylum Nematoda for example, plant parasitic nematodes such as root-knot nematodes, Meloidogyne spp. such as M. hapla, M. incognita, M. javanica; cyst-forming nematodes, Globodera spp. such as G. rostochiensis; Heterodera spp. such as H. avenae, H. glycines, H. schachtii, H. trifolii; Seed gall nematodes, Anguina spp.; Stem and foliar
  • nematodes Aphelenchoides spp. such as A. besseyi; Sting nematodes, Belonolaimus spp. such as B. longicaudatus; Pine nematodes, Bursaphelenchus spp. such as B. lignicolus, B. xylophilus; Ring nematodes, Criconema spp., Criconemella spp. such as C. xenoplax and C. ornata; and, Criconemoides spp. such as Criconemoides informis; Mesocriconema spp.; Stem and bulb nematodes, Ditylenchus spp. such as D.
  • D. dipsaci Awl nematodes, Dolichodorus spp.; Spiral nematodes, Heliocotylenchus multicinctus; Sheath and sheathoid nematodes, Hemicycliophora spp. and Hemicriconemoides spp.; Hirshmanniella spp.; Lance nematodes, Hoploaimus spp.; False rootknot nematodes, Nacobbus spp.; Needle nematodes, Longidorus spp. such as L. elongatus; Lesion nematodes, Pratylenchus spp. such as P.
  • brachyurus P. neglectus, P. penetrans, P. curvitatus, P. goodeyi; Burrowing nematodes, Radopholus spp. such as R. similis; Rhadopholus spp.; Rhodopholus spp.; Reniform
  • nematodes Rotylenchus spp. such as R. robustus, R. reniformis; Scutellonema spp.; Stubby- root nematode, Trichodorus spp. such as T. obtusus, T. primitivus; Paratrichodorus spp. such as P. minor; Stunt nematodes, Tylenchorhynchus spp. such as T. claytoni, T. dubius; Citrus nematodes, Tylenchulus spp. such as T. semipenetrans; Dagger nematodes, Xiphinema spp.; and other plant parasitic nematode species;
  • Insects from the order Isoptera for example Calotermes flavicollis, Coptotermes spp. such as C. formosanus, C. gestroi, C. acinaciformis; Cornitermes cumulans, Cryptotermes spp. such as C. brevis, C. cavifrons; Globitermes sulfureus, Heterotermes spp. such as H. aureus, H.
  • Neocapritermes spp. such as N. opacus, N. parvus; Neotermes spp., Procornitermes spp., Zootermopsis spp. such as Z. angusticollis, Z. nevadensis, Reticulitermes spp. such as R.
  • Blattella spp. such as B. asahinae, B. germanica; Leucophaea maderae, Panchlora nivea, Periplaneta spp. such as P. americana, P. australasiae, P. brunnea, P. fuligginosa, P. japonica; Supella longipalpa, Pa rco blatta pennsylvanica, Eurycotis floridana, Pycnoscelus surinamensis,
  • Insects from the order Siphonoptera for example Cediopsylla simples, Ceratophyllus spp., Ctenocephalides spp. such as C. felis, C. canis, Xenopsylla cheopis, Pulex irritans,
  • Thysanura for example Lepisma saccharina , Ctenolepisma urbana, and Thermobia domestica
  • Pests from the class Chilopoda for example Geophilus spp., Scutigera spp. such as Scutigera coleoptrata;
  • Pests from the class Diplopoda for example Blaniulus guttulatus, Julus spp., Narceus spp.
  • Pests from the class Symphyla for example Scutigerella immaculata
  • Insects from the order Collembola for example Onychiurus spp., such as Onychiurus armatus, Pests from the order Isopoda for example, Armadillidium vulgare, Oniscus asellus, Porcellio scaber,
  • Insects from the order Phthiraptera for example Damalinia spp., Pediculus spp. such as Pediculus humanus capitis, Pediculus humanus corporis, Pediculus humanus humanus; Pthirus pubis, Haematopinus spp. such as Haematopinus eurysternus, Haematopinus suis;
  • Linognathus spp. such as Linognathus vituli; Bovicola bovis, Menopon gallinae, Menacanthus stramineus and Solenopotes capillatus, Trichodectes spp.,
  • Examples of further pest species which may be controlled by compounds of fomula (I) include: from the Phylum Mollusca, class Bivalvia, for example, Dreissena spp.; class Gastropoda, for example, Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania spp., Pomacea canaliclata, Succinea spp.; from the class of the helminths, for example, Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia timori, Bunostomum spp., Chabertia spp., Clonorchis spp
  • Haemonchus contortus such as Haemonchus contortus; Heterakis spp., Hymenolepis nana, Hyostrongulus spp., Loa Loa, Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp.,
  • the compounds of the present invention are suitable for use in treating or protecting animals against infestation or infection by parasites. Therefore, the present invention also relates to the use of a compound of the present invention for the manufacture of a medicament for the treatment or protection of animals against infestation or infection by parasites. Furthermore, the present invention relates to a method of treating or protecting animals against infestation and infection by parasites, which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of a compound of the present invention.
  • the present invention also relates to the non-therapeutic use of compounds of the present invention for treating or protecting animals against infestation and infection by parasites.
  • the present invention relates to a non-therapeutic method of treating or protecting animals against infestation and infection by parasites, which comprises applying to a locus a parasiticidally effective amount of a compound of the present invention.
  • the compounds of the present invention are further suitable for use in combating or controlling parasites in and on animals. Furthermore, the present invention relates to a method of combating or controlling parasites in and on animals, which comprises contacting the parasites with a parasitically effective amount of a compound of the present invention.
  • the present invention also relates to the non-therapeutic use of compounds of the present invention for controlling or combating parasites. Moreover, the present invention relates to a non-therapeutic method of combating or controlling parasites, which comprises applying to a locus a parasiticidally effective amount of a compound of the present invention.
  • the compounds of the present invention can be effective through both contact (via soil, glass, wall, bed net, carpet, blankets or animal parts) and ingestion (e.g. baits). Furthermore, the compounds of the present invention can be applied to any and all developmental stages.
  • the compounds of the present invention can be applied as such or in form of compositions comprising the compounds of the present invention.
  • the compounds of the present invention can also be applied together with a mixing partner, which acts against pathogenic parasites, e.g. with synthetic coccidiosis compounds, polyetherantibiotics such as Amprolium, Robenidin, Toltrazuril, Monensin, Salinomycin, Maduramicin, Lasalocid, Narasin or Semduramicin, or with other mixing partners as defined above, or in form of compositions comprising said mixtures.
  • the compounds of the present invention and compositions comprising them can be applied orally, parenterally or topically, e.g. dermally.
  • the compounds of the present invention can be systemically or non-systemically effective.
  • the application can be carried out prophylactically, therapeutically or non-therapeutically. Furthermore, the application can be carried out preventively to places at which occurrence of the parasites is expected.
  • contacting includes both direct contact (applying the
  • locus means the habitat, food supply, breeding ground, area, material or environment in which a parasite is growing or may grow outside of the animal.
  • parasites includes endo- and ectoparasites. In some embodiments of the present invention, endoparasites can be preferred. In other embodiments, ectoparasites can be preferred. Infestations in warm-blooded animals and fish include, but are not limited to, lice, biting lice, ticks, nasal bots, keds, biting flies, muscoid flies, flies, myiasitic fly larvae, chiggers, gnats, mosquitoes and fleas.
  • the compounds of the present invention are especially useful for combating parasites of the following orders and species, respectively:
  • fleas e.g. Ctenocephalides felis, Ctenocephalides cams, Xenopsylla cheopis, Pulex irritans, Tunga penetrans, and Nosopsyllus fasciatus
  • cockroaches e.g. Blattella germanica, Blattella asahinae, Periplaneta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta australasiae, and Blatta orientalis
  • flies mosquitoes (Diptera), e.g.
  • Phlebotomus argentipes Psorophora columbiae, Psorophora discolor, Prosimulium mixtum, Sarcophaga haemorrhoidalis, Sarcophaga sp., Simulium vittatum, Stomoxys calcitrans,
  • Cytodites spp., and Laminosioptes spp Bugs (Heteropterida): Cimex lectularius, Cimex hemipterus, Reduvius senilis, Triatoma spp., Rhodnius ssp., Panstrongylus ssp., and Arilus critatus; Anoplurida, e.g. Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., and Solenopotes spp.; Mallophagida (suborders Arnblycerina and Ischnocerina), e.g.
  • Trimenopon spp. Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Trichodectes spp., and Felicola spp.; Roundworms Nematoda: Wipeworms and
  • Trichinosis Trichosyringida
  • Trichinellidae Trichinella spp.
  • Trichuridae Trichuris spp. Capillaria spp.
  • Rhabditida e.g. Rhabditis spp., Strongyloides spp., Helicephalobus spp.
  • Hcephalobus spp. Trichinosis
  • Strongylida e.g. Strongylus spp., Ancylostoma spp., Necator americanus, Bunostomum spp. (Hookworm), Trichostrongylus spp., Haemonchus contortus, Ostertagia spp., Cooperia spp., Nematodirus spp., Dictyocaulus spp., Cyathostoma spp., Oesophagostomum spp., Stephanurus dentatus, Ollulanus spp., Chabertia spp., Stephanurus dentatus, Syngamus trachea,
  • Ancylostoma spp. Uncinaria spp., Globocephalus spp., Necator spp., Metastrongylus spp., Muellerius capillaris, Protostrongylus spp., Angiostrongylus spp., Parelaphostrongylus spp., Aleurostrongylus abstrusus, and Dioctophyma renale; Intestinal roundworms (Ascaridida), e.g. Ascaris lumbricoides, Ascaris suum, Ascaridia galli, Parascaris equorum, Enterobius
  • Toxocara canis Toxascaris leonine, Skrjabinema spp., and Oxyuris equi
  • Camallanida e.g. Dracunculus medinensis (guinea worm)
  • Spirurida e.g. Thelazia spp., Wuchereria spp., Brugia spp., Onchocerca spp., Dirofilari spp. a, Dipetalonema spp., Setaria spp., Elaeophora spp., Spirocerca lupi, and Habronema spp.
  • Acanthocephala e.g. Acanthocephalus spp., Macracanthorhynchus hirudinaceus and
  • Faciola spp. Fascioloides magna
  • Paragonimus spp. Dicrocoelium spp.
  • Fasciolopsis buski Clonorchis sinensis
  • Schistosoma spp. Trichobilharzia spp., Alaria alata, Paragonimus spp., and Nanocyetes spp.; Cercomeromorpha, in particular Cestoda (Tapeworms), e.g.
  • Diphyllobothrium spp. Diphyllobothrium spp., Tenia spp., Echinococcus spp., Dipylidium caninum, Multiceps spp., Hymenolepis spp., Mesocestoides spp., Vampirolepis spp., Moniezia spp., Anoplocephala spp., Sirometra spp., Anoplocephala spp., and Hymenolepis spp..
  • animal includes warm-blooded animals (including humans) and fish.
  • mammals such as cattle, sheep, swine, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, water buffalo, donkeys, fallow deer and reindeer, and also in fur- bearing animals such as mink, chinchilla and raccoon, birds such as hens, geese, turkeys and ducks and fish such as fresh- and salt-water fish such as trout, carp and eels.
  • domestic animals such as dogs or cats.
  • parasiticidally effective amount means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism.
  • the parasiticidally effective amount can vary for the various conditions.
  • a parasiticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired parasiticidal effect and duration, target species, mode of application, and the like.
  • the compounds of the present invention in total amounts of 0.5 mg/kg to 100 mg/kg per day, preferably 1 mg/kg to 50 mg/kg per day.
  • the formula I compounds may be formulated as animal feeds, animal feed premixes, animal feed concentrates, pills, solutions, pastes, suspensions, drenches, gels, tablets, boluses and capsules.
  • the formula I compounds may be administered to the animals in their drinking water.
  • the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound, preferably with 0.5 mg/kg to 100 mg/kg of animal body weight per day.
  • the formula I compounds may be administered to animals parenterally, for example, by intraruminal, intramuscular, intravenous or subcutaneous injection.
  • the formula I compounds may be dispersed or dissolved in a physiologically acceptable carrier for subcutaneous injection.
  • the formula I compounds may be formulated into an implant for subcutaneous administration.
  • the formula I compound may be
  • the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound.
  • the formula I compounds may also be applied topically to the animals in the form of dips, dusts, powders, collars, medallions, sprays, shampoos, spot-on and pour-on formulations and in ointments or oil-in-water or water-in-oil emulsions.
  • dips and sprays usually contain 0.5 ppm to 5,000 ppm and preferably 1 ppm to 3,000 ppm of the formula I compound.
  • the formula I compounds may be formulated as ear tags for animals, particularly quadrupeds such as cattle and sheep.
  • Suitable preparations are:
  • Solutions such as oral solutions, concentrates for oral administration after dilution, solutions for use on the skin or in body cavities, pouring-on formulations, gels;
  • Solid preparations such as powders, premixes or concentrates, granules, pellets, tablets, boluses, capsules; aerosols and inhalants, and active compound-containing shaped articles.
  • compositions suitable for injection are prepared by dissolving the active ingredient in a suitable solvent and optionally adding further auxiliaries such as acids, bases, buffer salts, preservatives, and solubilizers.
  • auxiliaries for injection solutions are known in the art.
  • the solutions are filtered and filled sterile.
  • Oral solutions are administered directly. Concentrates are administered orally after prior dilution to the use concentration.
  • Oral solutions and concentrates are prepared according to the state of the art and as described above for injection solutions, sterile procedures not being necessary.
  • Solutions for use on the skin are trickled on, spread on, rubbed in, sprinkled on or sprayed on. Solutions for use on the skin are prepared according to the state of the art and according to what is described above for injection solutions, sterile procedures not being necessary.
  • Gels are applied to or spread on the skin or introduced into body cavities. Gels are prepared by treating solutions which have been prepared as described in the case of the injection solutions with sufficient thickener that a clear material having an ointment-like consistency results. Suitable thickeners are known in the art.
  • Pour-on formulations are poured or sprayed onto limited areas of the skin, the active compound penetrating the skin and acting systemically.
  • Pour-on formulations are prepared by dissolving, suspending or emulsifying the active compound in suitable skin-compatible solvents or solvent mixtures.
  • suitable skin-compatible solvents or solvent mixtures If appropriate, other auxiliaries such as colorants, bioabsorption-promoting substances, antioxidants, light stabilizers, adhesives are added. Suitable such auxiliaries are known in the art.
  • Emulsions can be administered orally, dermally or as injections.
  • Emulsions are either of the water-in-oil type or of the oil-in-water type. They are prepared by dissolving the active compound either in the hydrophobic or in the hydrophilic phase and homogenizing this with the solvent of the other phase with the aid of suitable emulsifiers and, if appropriate, other auxiliaries such as colorants, absorption-promoting substances, preservatives, antioxidants, light stabilizers, viscosity-enhancing substances.
  • suitable hydrophobic phases (oils), suitable hydrophilic phases, suitable emulsifiers, and suitable further auxiliaries for emulsions are known in the art.
  • Suspensions can be administered orally or topically/dermally. They are prepared by suspending the active compound in a suspending agent, if appropriate with addition of other auxiliaries such as wetting agents, colorants, bioabsorption-promoting substances,
  • Suitable suspending agents, and suitable other auxiliaries for suspensions including wetting agents are known in the art.
  • Semi-solid preparations can be administered orally or topically/dermally. They differ from the suspensions and emulsions described above only by their higher viscosity.
  • the active compound is mixed with suitable excipients, if appropriate with addition of auxiliaries, and brought into the desired form.
  • suitable auxiliaries for this purpose are known in the art.
  • compositions which can be used in the invention can comprise generally from about 0.001 to 95% of the compound of the present invention.
  • Ready-to-use preparations contain the compounds acting against parasites, preferably ectoparasites, in concentrations of 10 ppm to 80 per cent by weight, preferably from 0.1 to 65 per cent by weight, more preferably from 1 to 50 per cent by weight, most preferably from 5 to 40 per cent by weight.
  • Preparations which are diluted before use contain the compounds acting against ectoparasites in concentrations of 0.5 to 90 per cent by weight, preferably of 1 to 50 per cent by weight.
  • the preparations comprise the compounds of formula I against endoparasites in concentrations of 10 ppm to 2 per cent by weight, preferably of 0.05 to 0.9 per cent by weight, very particularly preferably of 0.005 to 0.25 per cent by weight.
  • Topical application may be conducted with compound-containing shaped articles such as collars, medallions, ear tags, bands for fixing at body parts, and adhesive strips and foils.
  • compound-containing shaped articles such as collars, medallions, ear tags, bands for fixing at body parts, and adhesive strips and foils.
  • solid formulations which release compounds of the present invention in total amounts of 10 mg/kg to 300 mg/kg, preferably 20 mg/kg to 200 mg/kg, most preferably 25 mg/kg to 160 mg/kg body weight of the treated animal in the course of three weeks.
  • Step-1
  • IA-7 2-methyl-3-methylsulfanyl-1 -[6- 1.15 (t, 3H), 2.01 (s, 3H), 2.65-2.73 (m, 1H), 2.89-3.02 (3-pyridyl)pyrrolo[3,2-c]pyridin- (m, 1H), 3.76-3.85 (m, 1H), 6.98-6.99 (m,1H), 7.51- 1-yl]propan-1-one 7.56 (m, 1H), 8.24-8.25 (m, 1H), 8.40-8.43 (m, 1H),
  • the active compound is dissolved at the desired concentration in a mixture of 1 :1 (vohvol) distilled water : acteone.
  • the test solution is prepared at the day of use.
  • Test solutions are prepared in general at concentrations of 1000 ppm, 500 ppm, 300 ppm, 100 ppm and 30 ppm (wtvol).
  • the active compounds were formulated by a Tecan liquid handler in 100% cyclohexanone as a 10,000 ppm solution supplied in tubes.
  • the 10,000 ppm solution was serially diluted in 100% cyclohexanone to make interim solutions.
  • These served as stock solutions for which final dilutions were made by the Tecan in 50% acetone: 50% water (v/v) into 10 or 20ml glass vials.
  • a nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v).
  • the vials were then inserted into an automated electrostatic sprayer equipped with an atomizing nozzle for application to plants/insects.
  • Cotton plants at the cotyledon stage were infested with aphids prior to treatment by placing a heavily infested leaf from the main aphid colony on top of each cotyledon. Aphids were allowed to transfer overnight to accomplish an infestation of 80-100 aphids per plant and the host leaf was removed. The infested plants were then sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood, removed from the sprayer, and then maintained in a growth room under fluorescent lighting in a 24-hr photoperiod at 25°C and 20-40% relative humidity. Aphid mortality on the treated plants, relative to mortality on untreated control plants, was determined after 5 days. In this test, compounds IA-4, IA-6, IA-9 at 300 ppm showed at least 75% mortality in comparison with untreated controls.
  • the active compound is dissolved at the desired concentration in a mixture of 1 :1 (vohvol) distilled water : acetone.
  • Surfactant Kinetic® HV
  • the test solution is prepared at the day of use.
  • the active compounds were formulated by a Tecan liquid handler in 100% cyclohexanone as a 10,000 ppm solution supplied in tubes.
  • the 10,000 ppm solution was serially diluted in 100% cyclohexanone to make interim solutions.
  • These served as stock solutions for which final dilutions were made by the Tecan in 50% acetone: 50% water (v/v) into 10or 20ml glass vials.
  • a nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v).
  • the vials were then inserted into an automated electrostatic sprayer equipped with an atomizing nozzle for application to plants/insects.
  • Bell pepper plants at the first true-leaf stage were infested prior to treatment by placing heavily infested leaves from the main colony on top of the treatment plants. Aphids were allowed to transfer overnight to accomplish an infestation of 30-50 aphids per plant and the host leaves were removed. The infested plants were then sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood, removed, and then maintained in a growth room under fluorescent lighting in a 24-hr photoperiod at about 25°C and about 20-40% relative humidity. Aphid mortality on the treated plants, relative to mortality on untreated control plants, was determined after 5 days.
  • test unit For evaluating control of vetch aphid (Megoura viciae) through contact or systemic means the test unit consisted of 24-well-microtiter plates containing broad bean leaf disks.
  • the compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the leaf disks at 2.5 ⁇ , using a custom built micro atomizer, at two replications.
  • the leaf disks were air-dried and 5 - 8 adult aphids placed on the leaf disks inside the microtiter plate wells. The aphids were then allowed to suck on the treated leaf disks and incubated at about 23 + 1 °C and about 50 + 5 % relative humidity for 5 days. Aphid mortality and fecundity was then visually assessed.
  • the active compounds were formulated by a Tecan liquid handler in 100% cyclohexanone as a 10,000 ppm solution supplied in tubes.
  • the 10,000 ppm solution was serially diluted in 100% cyclohexanone to make interim solutions.
  • These served as stock solutions for which final dilutions were made by the Tecan in 50% acetone: 50% water (v/v) into 5 or 10ml glass vials.
  • a nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v).
  • the vials were then inserted into an automated electrostatic sprayer equipped with an atomizing nozzle for application to plants/insects.
  • Cotton plants at the cotyledon stage were sprayed by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood and then removed from the sprayer. Each pot was pla-ced into a plastic cup and about 10 to 12 whitefly adults (approximately 3-5 days old) were introduced. The insects were collected using an aspirator and a nontoxic Tygon® tubing connected to a barrier pipette tip. The tip, containing the collected insects, was then gently inserted into the soil containing the treated plant, allowing insects to crawl out of the tip to reach the foliage for feeding. Cups were covered with a reusable screened lid.
  • Test plants were maintained in a growth room at about 25°C and about 20-40% relative humidity for 3 days, avoiding direct exposure to fluorescent light (24 hour photoperiod) to prevent trapping of heat inside the cup. Mortality was assessed 3 days after treatment, compared to untreated control plants.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés de formule (I) dans laquelle les variables sont telles que définies dans la description et les revendications. L'invention concerne en outre des utilisations, une composition pour les composés de formule (I) et des procédés de lutte contre les nuisibles et de protection des plantes, consistant à appliquer des composés de formule (I).
PCT/EP2016/070847 2015-09-14 2016-09-05 Composés hétérobicycliques Ceased WO2017045955A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3520/MUM/2015 2015-09-14
IN3520MU2015 2015-09-14

Publications (1)

Publication Number Publication Date
WO2017045955A1 true WO2017045955A1 (fr) 2017-03-23

Family

ID=56896531

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/070847 Ceased WO2017045955A1 (fr) 2015-09-14 2016-09-05 Composés hétérobicycliques

Country Status (1)

Country Link
WO (1) WO2017045955A1 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018152220A1 (fr) * 2017-02-15 2018-08-23 Incyte Corporation Composés de pyrazolopyridine et leurs utilisations
US10266530B2 (en) 2016-09-09 2019-04-23 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US10280164B2 (en) 2016-09-09 2019-05-07 Incyte Corporation Pyrazolopyridone compounds and uses thereof
US10383335B2 (en) 2015-04-09 2019-08-20 Fmc Corporation Bicyclic pyrazole pesticides
US10526264B2 (en) 2016-07-07 2020-01-07 Basf Se Oxy-cope rearrangement for the manufacture of insecticidal cyclopentene compounds
US10647692B2 (en) 2015-03-12 2020-05-12 Fmc Corporation Heterocycle-substituted bicyclic azole pesticides
US10722495B2 (en) 2017-09-08 2020-07-28 Incyte Corporation Cyanoindazole compounds and uses thereof
US10745388B2 (en) 2018-02-20 2020-08-18 Incyte Corporation Indazole compounds and uses thereof
US10752635B2 (en) 2018-02-20 2020-08-25 Incyte Corporation Indazole compounds and uses thereof
US10800761B2 (en) 2018-02-20 2020-10-13 Incyte Corporation Carboxamide compounds and uses thereof
US10899755B2 (en) 2018-08-08 2021-01-26 Incyte Corporation Benzothiazole compounds and uses thereof
US11014929B2 (en) 2016-09-09 2021-05-25 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US11066394B2 (en) 2019-08-06 2021-07-20 Incyte Corporation Solid forms of an HPK1 inhibitor
US11111247B2 (en) 2018-09-25 2021-09-07 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US11242343B2 (en) 2016-09-09 2022-02-08 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US11299473B2 (en) 2018-04-13 2022-04-12 Incyte Corporation Benzimidazole and indole compounds and uses thereof
US11570992B2 (en) 2016-04-01 2023-02-07 Basf Se Bicyclic compounds

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003080616A1 (fr) * 2002-03-21 2003-10-02 Glaxo Group Limited Derives de pyrazolopyridazine, leur procede de preparation et leur utilisation pour l'inhibition de gsk-3
WO2011019780A1 (fr) * 2009-08-11 2011-02-17 Bristol-Myers Squibb Company Azaindazoles comme modulateurs de la kinase btk et leur utilisation
WO2011087776A1 (fr) * 2009-12-22 2011-07-21 Vertex Pharmaceuticals Incorporated Inhibiteurs d'isoindolinone de phosphatidylinositol 3-kinase
WO2012086735A1 (fr) * 2010-12-22 2012-06-28 大正製薬株式会社 Composé hétérocyclique condensé
US20130039906A1 (en) * 2011-08-12 2013-02-14 Steven Do PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
US20140005168A1 (en) * 2012-06-27 2014-01-02 Genentech, Inc. 5-azaindazole compounds and methods of use
WO2014066836A1 (fr) * 2012-10-25 2014-05-01 Usher Iii Initiative, Inc. Pyrazolopyridazines et méthodes de traitement de maladies dégénératives de la rétine et de la perte d'audition associée au syndrome d'usher
EP2818472A1 (fr) * 2013-06-27 2014-12-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composés d' Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine comme modulateurs de kinase 5 des récepteurs couplés à la protéine G (GRK5)
WO2015026683A1 (fr) * 2013-08-22 2015-02-26 Merck Sharp & Dohme Corp. Composés inhibant l'activité enzymatique de la kinase à répétitions riches en leucine
WO2015038503A1 (fr) * 2013-09-13 2015-03-19 E. I. Du Pont De Nemours And Company Pesticides à base d'azole bicyclique substitué par un hétérocycle

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003080616A1 (fr) * 2002-03-21 2003-10-02 Glaxo Group Limited Derives de pyrazolopyridazine, leur procede de preparation et leur utilisation pour l'inhibition de gsk-3
WO2011019780A1 (fr) * 2009-08-11 2011-02-17 Bristol-Myers Squibb Company Azaindazoles comme modulateurs de la kinase btk et leur utilisation
WO2011087776A1 (fr) * 2009-12-22 2011-07-21 Vertex Pharmaceuticals Incorporated Inhibiteurs d'isoindolinone de phosphatidylinositol 3-kinase
WO2012086735A1 (fr) * 2010-12-22 2012-06-28 大正製薬株式会社 Composé hétérocyclique condensé
US20130039906A1 (en) * 2011-08-12 2013-02-14 Steven Do PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
US20140005168A1 (en) * 2012-06-27 2014-01-02 Genentech, Inc. 5-azaindazole compounds and methods of use
WO2014066836A1 (fr) * 2012-10-25 2014-05-01 Usher Iii Initiative, Inc. Pyrazolopyridazines et méthodes de traitement de maladies dégénératives de la rétine et de la perte d'audition associée au syndrome d'usher
EP2818472A1 (fr) * 2013-06-27 2014-12-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composés d' Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine comme modulateurs de kinase 5 des récepteurs couplés à la protéine G (GRK5)
WO2015026683A1 (fr) * 2013-08-22 2015-02-26 Merck Sharp & Dohme Corp. Composés inhibant l'activité enzymatique de la kinase à répétitions riches en leucine
WO2015038503A1 (fr) * 2013-09-13 2015-03-19 E. I. Du Pont De Nemours And Company Pesticides à base d'azole bicyclique substitué par un hétérocycle

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADAMS C ET AL: "Mapping the kinase domain of janus kinase 3", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 13, no. 18, 1 January 2003 (2003-01-01), pages 3105 - 3110, XP002349882, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(03)00657-7 *
GYTE VILKAUSKAITE: "Synthesis of pyridyl substituted pyrazolo[4,3-c]pyridines as potential inhibitors of protein kinases", ARKIVOC, vol. 2014, no. 2, 8 April 2013 (2013-04-08), US, pages 135, XP055313979, ISSN: 1551-7004, DOI: 10.3998/ark.5550190.p008.188 *

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10647692B2 (en) 2015-03-12 2020-05-12 Fmc Corporation Heterocycle-substituted bicyclic azole pesticides
US10383335B2 (en) 2015-04-09 2019-08-20 Fmc Corporation Bicyclic pyrazole pesticides
US11570992B2 (en) 2016-04-01 2023-02-07 Basf Se Bicyclic compounds
US10526264B2 (en) 2016-07-07 2020-01-07 Basf Se Oxy-cope rearrangement for the manufacture of insecticidal cyclopentene compounds
US12516059B2 (en) 2016-09-09 2026-01-06 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US10435405B2 (en) 2016-09-09 2019-10-08 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US10280164B2 (en) 2016-09-09 2019-05-07 Incyte Corporation Pyrazolopyridone compounds and uses thereof
US12384778B2 (en) 2016-09-09 2025-08-12 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US11891388B2 (en) 2016-09-09 2024-02-06 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US11795166B2 (en) 2016-09-09 2023-10-24 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US10934288B2 (en) 2016-09-09 2021-03-02 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US11014929B2 (en) 2016-09-09 2021-05-25 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US10266530B2 (en) 2016-09-09 2019-04-23 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US11542265B2 (en) 2016-09-09 2023-01-03 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US11242343B2 (en) 2016-09-09 2022-02-08 Incyte Corporation Pyrazolopyridine compounds and uses thereof
WO2018152220A1 (fr) * 2017-02-15 2018-08-23 Incyte Corporation Composés de pyrazolopyridine et leurs utilisations
US11406624B2 (en) 2017-02-15 2022-08-09 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US10722495B2 (en) 2017-09-08 2020-07-28 Incyte Corporation Cyanoindazole compounds and uses thereof
US10800761B2 (en) 2018-02-20 2020-10-13 Incyte Corporation Carboxamide compounds and uses thereof
US11492354B2 (en) 2018-02-20 2022-11-08 Incyte Corporation Indazole compounds and uses thereof
US10745388B2 (en) 2018-02-20 2020-08-18 Incyte Corporation Indazole compounds and uses thereof
US12466815B2 (en) 2018-02-20 2025-11-11 Incyte Corporation Carboxamide compounds and uses thereof
US11731958B2 (en) 2018-02-20 2023-08-22 Incyte Corporation Carboxamide compounds and uses thereof
US10752635B2 (en) 2018-02-20 2020-08-25 Incyte Corporation Indazole compounds and uses thereof
US11299473B2 (en) 2018-04-13 2022-04-12 Incyte Corporation Benzimidazole and indole compounds and uses thereof
US10899755B2 (en) 2018-08-08 2021-01-26 Incyte Corporation Benzothiazole compounds and uses thereof
US11866426B2 (en) 2018-08-08 2024-01-09 Incyte Corporation Benzothiazole compounds and uses thereof
US12441731B2 (en) 2018-09-25 2025-10-14 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US11111247B2 (en) 2018-09-25 2021-09-07 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
US11787784B2 (en) 2019-08-06 2023-10-17 Incyte Corporation Solid forms of an HPK1 inhibitor
US11066394B2 (en) 2019-08-06 2021-07-20 Incyte Corporation Solid forms of an HPK1 inhibitor

Similar Documents

Publication Publication Date Title
EP3436457B1 (fr) Composés bicycliques
JP7161823B2 (ja) 動物有害生物を駆除するためのピリミジニウム化合物及びそれらの混合物
WO2017045955A1 (fr) Composés hétérobicycliques
EP3601231B1 (fr) Composés pesticides
EP3621967B1 (fr) Composés pesticides bicycliques
EP3555050A1 (fr) Composés pesticides
CN107873027A (zh) 用于防治无脊椎动物害虫的3‑吡啶基杂双环化合物
WO2015114106A1 (fr) Pyrazoles pour la lutte contre les invertébrés nuisibles
WO2018224455A1 (fr) Dérivés de cyclopropyle substitués
WO2017153217A1 (fr) Dérivés spirocycliques
EP3453706A1 (fr) Composés pesticides de l'imizazole
US10106558B2 (en) Azolobenzazine compounds, compositions comprising these compounds and their use for controlling invertebrate pests
WO2018162312A1 (fr) Dérivés spirocycliques
WO2018192793A1 (fr) Dérivés de rhodanine substitués
EP3887357A1 (fr) Composés pesticides
WO2018166855A1 (fr) Dihydroisoxazoles à substitution hétérobicyclique
BR112019022316B1 (pt) Composto, composição, método não terapêutico de controle ou combate a pragas invertebradas, método de proteção de plantas, semente revestida e usos de um composto

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16763493

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16763493

Country of ref document: EP

Kind code of ref document: A1